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ABSTRACT 
Furans, due to their easy preparation and great synthetic versatility, are widely used as 
intermediates in organic synthesis and as building blocks in the preparation of a wide 
number of natural and synthetic compounds interesting from a pharmacological point 
of view. This encourages to explore for novel preparation methods, and new synthetic 
applications of this system. In the first part of this thesis one-pot syntheses for new 
functionalized glycosides and new modified nucleosides of biological interes have been 
developed. The strategy is based on the preparation of glycosyl furans used as 
precursors in reactions of [4+2] cycloaddition with singlet oxygen, generated by dye-
sensitized photooxygenation, and subsequent elaborations. In this context, novel and 
highly functionalized spiroketals of sugars were synthetized. The spiroketal moiety 
represents a privileged substructure since it can be found in many natural products 
characterized by various important biological properties, from antibiotic to anticancer. 
The second part of the thesis was devoted to study polysubstituted furans as 
precursors of lignan-like compounds. Lignans are widespread plant secondary 
metabolites holding a large series of bioactivities. Basic structure consists of two 
phenylpropanoidic units linked in different patterns. To isolate lignans from plant 
materials is a laborious and expensive process. For this over the years diverse synthetic 
approaches have been proposed, mainly based on coupling of C6C3 units. As an 
alternative, a novel methodology to obtain ’ linked lignan-like products was found, 
based on the use of aryl substituted furans. In particular, a Tf2O-mediated Friedel-crafts 
reaction starting from furyl alcohols was examined and led to furans with lignan 
backbone. Moreover, in order to explain some peculiar results evidenced in “classical” 
reactions of the endoperoxides of ,’-dicarbomethoxy aryl furans, an investigation 
was carried out on the reactivity of these compounds by examining mainly substituent 
effects. The synthetic potential was also exploited. The introduction of furan system in 
the lignan scaffold was inspired by the chemical properties of furans that are efficiently 
converted into reduced forms as dihydro- and tetrahydrofurans or to oxidized forms as 
furanones or enediones. Therefore, further elaborations can be expected that enlarge 
the number of  derivatives with lignan bakbone. 
 
 
CONTEXT 
ABSTRACT 
CHAPTER 1.   INTRODUCTION 
          Furans: synthesis and reactivity  
                         Dye-sensitized photooxygenation of furans 
                     1A.  THE PROJECT 
CHAPTER 2.   SYNTHESIS OF GLYCOSYL FURANS AND APPLICATIONS IN THE FIELD OF 
                          C-GLYCOSIDES AND C-NUCLEOSIDES 
  2.   INTRODUCTION 
                 2A.  ONE-POT PROCEDURE FOR NOVEL SPIROKETALS OF MONOSACCHARIDES  
                              RESULTS AND DISCUSSION: 
                       Synthesis of Glycosyl Furans 2 
                       Dye-Sensitized Photooxygenation of Furans 2a-2c and Et2S Reduction     
                  2B.   ONE-POT PROCEDURE FOR 1,2-PYRIDAZINE C-NUCLEOSIDES 
                                   RESULTS AND DISCUSSION: 
                                   Preparation of starting -Glycosyl Furans 3 
                           Synthesis of 1,2-Pyridazine C-Nucleosides  
                  2C.    CONCLUSION  
               2D.    EXPERIMENTAL SECTION 
                          Experimental-part 2A 
                          Experimental- part 2B 
   CHAPTER 3.  SYNTHESIS OF ARYL TRISUBSTITUTED FURANS AND APPLICATIONS IN THE 
                             FIELD OF LIGNANS 
                     3.    INTRODUCTION 
                   3A.  SYNTHESIS OF DIARYL FURANS WITH LIGNAN BACKBONE BY NOVEL     
                           FRIEDEL-CRAFTS ALKYLATION  
                           RESULTS AND DISCUSSION: 
 
 
                              Synthesis of  furans  1 
                             Synthesis of  furanyl alcohols  2 
                          Friedel-Crafts alkylation reactions 
                                    Antibiotic activity of some derivatives 
                    3B. DYE-SENSITIZED PHOTOOXYGENATION OF ARYL TRISUBSTITUTED FURANS 
                             AND APPLICATIONS IN THE FIELD OF LIGNANS   
                                     RESULTS AND DISCUSSION: 
                                     Synthesis of other furans of type 1 
                                     Photooxygenation reactions  
                              Et2S reduction 
                             Base treatment 
                             Mb-sensityzed photooxygenation of furans 1 in acetone 
                         3C.  CONCLUSION 
                         3D. EXPERIMENTAL SECTION 
                                   Experimental-part 3A 
                           Experimental- part 3B 
     CHAPTER 4. CONCLUSION AND PERSPECTIVES  
      REFERENCES 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 1. INTRODUCTION 
 
The name furan comes from the Latin furfur, which means bran. The first furan 
derivative to be described was 2-furoic acid, by Carl Wilhelm Scheele in 1780 (Senning 
2006). Furans are an important class of heterocyclic compounds, often possessing 
biological properties such as antibacterial, analgesic, antihyperglycemic, antifungal, 
antitumoral (Manna and Agraval 2009). The furan ring system is the basic skeleton of 
numerous compounds possessing cardiovascular activities. An iodinated lipophilic furan 
derivative is widely used in the treatment of ventricular and arterial fibrillation (Verma 
et al. 2011). Some examples of furans and derivatives are used in the treatment of 
diabetes (Nakanishi 1974). 
Furans are also versatile building blocks in organic synthesis and are used in the  
preparation of a wide number of important natural and synthetic compounds (Keay et 
al. 2008; Wong et al. 2008; Lee et al. 2005). Furans, indeed, find a large number of 
applications in the field of drugs, pesticides, cosmetics, detergents, polymers, dyes and 
so on.  
Hence, considerable attention is continuously focused on the synthesis of furan 
derivatives and screening for pharmacological activity and/or for industrial applications. 
Furans: synthesis and reactivity 
The furan ring is the most popular heterocyclic system due to its versatility in several 
types of reactions (Donnelly et al. 1984; Sargent et al. 1984; Heaney et al. 1996; Sargent 
et al. 1979; Shipman 1994; Dean 1982; Bosshard and Eugster 1996)  and it is widely 
used in the synthesis of a lot of important  products (Wong et al. 2008; Lee et al. 2005). 
Hence, chemists have paid considerable attention to the development of ring synthesis 
and elaborations for this class of heterocycles.  
The acid-catalyzed cyclization of 1,4-dicarbonyl compounds and their surrogates, 
known as the Paal-Knorr synthesis, is one of the most popular methods for the 
preparation of furans and recently mechanistic details have been disclosed (Amarnath 
and Amarnath 1995)(SCHEME 1.1). 
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SCHEME 1.1 PAAL-KNORR SYNTHESIS 
Noteworty is the synthesis of furan derivatives by treatment of an α-halo ketone and a 
β-dicarbonyl compound with a base (Feist-Benary furan synthesis) (Carson and Wong 
1973) (SCHEME1.2). 
 
SCHEME1.2 FEIST-BENARY SYNTHESIS 
Many derivatives come from elaboration of a starting simple compound, in many cases 
deriving from natural sources as furfural, furyl alcohol, etc. (Kirk-Othmer 1980). 
Furans undergo a wide range of reactions. Typical reactions are electrophilic 
substitutions, Diels-Alder, reductions and oxidations. Substitution occurs preferentially 
at C-2 because the intermediate obtained by attaching a substituent at this position is 
more stable than the intermediate obtained by attaching a substituent at C-3. If both 
positions adjacent to the heteroatom are occupied, electrophilic substitution will take 
place at C-3. Diels-Alder reactions lead to a great number of complex structures that 
are intermediates in the synthesis of natural products (Kappe et al. 1997; Keay et al. 
1999). Among these structures are the so- called ‘ naked sugars’, important precursors 
for de novo syntheses of carbohydrates (Vogel 2000; Vogel 1998; Vogel 1990).The 
reduction into tetra- and dihydrofurans can be carried out under classical metal-
catalyzed hydrogenation. Typical catalysts used are Pd/C, Raney nickel and rhodium on 
alumina (Pei and Pei 2000). Furans can also be oxidized by classical reagents such as 
peracids, hydrogen peroxide, and metal oxides to give derivatives of synthetic utility 
and several reviews have been published on this topic (Gingerich et al. 1990; Sauter 
and Adam 1995; Ciufolini et al. 1998; Merino et al. 2000). Generally, 2,5-disubstituted 
  
 
furans provide 1,4 dicarbonyl compounds, instead 3,4-disubstituted furans give rise to 
butenolides (SCHEME 1.3).  
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SCHEME 1.3 SYNTHESIS OF 1,4-DICARBONYL COMPOUNDS AND BUTENOLIDES 
Several other procedures for the oxidation of furans are reported. These use reagents 
including bromine, tert-butyl-hydroperoxide (TBHP), N-bromosucinimide (NBS), singlet 
oxygen, dioxiranes and lead to various structures: in addition to 1,4-enediones and 
furanones diepoxides, epoxyfuranones, enolesters. Furanones, in particular, show a 
very interesting structural motif, widely occurring in bioactive natural and synthetic 
products (Bailly et al. 2008; De Silva et al. 1980; Gunasekera et al. 1996; De Rosa et al. 
1995). 1,4-Enediones are versatile systems that can be used as synthons for the 
preparation of diverse carbo- and heterocyclic compounds (Iesce and Cermola 2012; 
Merino et al. 2007; Piancatelli et al. 1994 ). Among oxidation procedures the reaction 
with singlet oxygen, generated by dye-sensitized photooxygenation, is one of the most 
used for the mild reaction conditions and efficiency and for the possibility to obtain 
interesting C-4 functionalities (Iesce et al. 2012; Noutsias and Vassilikogiannakis 2012; 
Merino et al. 2007; Feringa 1987). 
Dye-sensitized photooxygenation of furans 
The photooxygenation can be described as a reaction in which a combination of light 
and oxygen in the presence of a sensitizer allows to introduce oxygenated functions in a 
given substrate (Iesce et al. 2005). 
  
 
The reaction is based on the irradiation of a substrate in the presence of oxygen and a 
catalytic amount of a dye. The latter compound usually is a substance easily excited by 
the absorbance of visible radiations (sunlight), and, in coming back to the ground state 
molecule, it releases the absorbed energy to oxygen that changes its state converting 
to singlet state (SCHEME 1.4). 
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SCHEME 1.4 FORMATION OF SINGLET OXYGEN VIA SENSITIZER 
The most common sensitizers used in the reactions of photooxygenation are non-toxic 
dyes with structures that allow large electron delocalization; they can be artificial or 
natural dyes that absorb visible light. A typical dye is Methylene Blue (MB), the 
structure of which is shown in FIGURE 1.1. 
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FIGURE 1.1 METHYLENE BLUE STRUCTURE 
Halogenated or deuterated solvents, low temperatures, use of halogen lamps and the 
continuous oxygen flow favor the production of singlet oxygen and ensure a long 
lifetime of this species (order of seconds) (Iesce et al. 2005). 
Singlet oxygen is a very reactive species that adds to unsaturated systems to give 
peroxides and hydroperoxides (Frimer 1985) through the following paths: 
 [4 + 2] Cycloaddition with conjugated dienes  
  
 
 
 Addition to a double bond and subsequent fragmentation with  the 
formation of two carbonyl fragments 
 
 Reaction with alkenes having an allylic hydrogen, forming allyl 
hydroperoxides 
 
Furan is an excellent substrate for singlet oxygenation reactions. Indeed, singlet oxygen 
adds to the hetorocycle by a [4+2] cycloaddition, analogue to Diels-Alder reaction, in a 
quantitative and concerted reaction leading to 2,3,7-trioxabicyclo[2.2.1]-heptenes, also 
named furan endoperoxides (SCHEME 1.5).  
 
SCHEME 1.5 DYE-SENSITIZED PHOTOOXYGENATION 
Furan endoperoxides are generally thermally unstable and can afford characteristic 
rearranged products. Anyhow, the reactivity can be controlled working at subambient 
temperature. Studies have evidenced that straight correlations exist between the 
  
 
nature of the substituents present in the bicycle and the stability as well as the type of 
the observed final products (Graziano et al. 1982; Graziano et al. 1987; Scarpati et al. 
1998; Iesce and Cermola 2012). So, the thermal stability of the furan endoperoxides 
appears to depend on the -substituents and follows the order Me > Ph > H > OMe. 
The presence of an electron-withdrawing group at the  position, on the furan ring, 
enhances the thermal stability of the corresponding endoperoxides, which may be 
stable enough to be isolated and characterized by analytical and spectroscopic data 
(Graziano et al. 1980). The subsequent rearrangements of the intermediate 
endoperoxide depend on the nature of the -substituents as well as on the reaction 
conditions (Iesce and Cermola 2012; Merino et al. 2007; Gollnick and Griesbeck 1985). 
Epoxides, diepoxides, enol esters, enediones, ketoesters, epoxyfuranones, furanones 
are some of the products available from the photooxygenation of furans (SCHEME 1.6). 
SCHEME 1.6 SOME REARRANGEMENTS OF FURAN ENDOPEROXIDES 
  
 
The reaction of furans with singlet oxygen is widely used in diverse scientific fields. The 
mild reaction conditions of the dye-sensitized photooxygenation, and the great 
structural diversity of products available from this simple heterocycle via the 
corresponding endoperoxide are strongly appealing in organic synthesis. The 
conversion to butenolides and 1,4-dicarbonyl compounds are the most used 
applications due to the key roles of these derivatives (Iesce and Cermola 2012; 
Montagnon et al. 2008; Merino et al. 2007). 
As above evidenced, butenolides have found utility as precursors to complex lactone-
containing compounds, some of them exhibiting bioactive properties (Noutsias and 
Vassilikogiannakis 2012).  This functionality can be easily introduced by the action of 
singlet-oxygen-mediated reaction sequences starting from silylated furans (Katsumura 
et al. 1985;  Kernan and Faulkner 1988) or in the presence of a base starting from α,α’-
unsubstituted furans (Kernan and Faulkner 1988) or in basic medium (Graziano and 
Iesce 1985), in water or ionic liquids (Astarita et al. 2009) starting from α- and α,α’-
unsubstituted furans. Cis-1,4-enediones are prepared by low temperature 
photooxygenation followed by in situ treatment of the intermediate furan 
endoperoxides with reductants such as triphenylphosphine or dialkyl sulfides (Iesce et 
al. 2005; Gollnick and Griesbeck 1985; Graziano et al. 1980). These compounds are 
generally formed almost quantitatively and hence can be used without isolation. 
Indeed they represent useful synthons for carbo- and heterocyclic compounds (Iesce 
and Cermola 2012; Merino et al. 2007; Piancatelli et al. 1994). 
The high propensity of furans to add singlet oxygen also accounts for the wide use of 
some derivatives as trapping agents in environmental and biomedical analyses (Boule 
1999). 
 
 
 
 
 
  
 
1A.  THE PROJECT 
In this context, the PhD project has aimed to explore novel preparation methods to 
obtain molecules of biological interest using the furan system as starting material and 
simple and environmentally procedures. 
The work  was  focused : 
 to synthetize glycosyl furans and explore novel applications in the field of 
glycosides and modified nulclesides using the photooxygenation as key step 
(SCHEME 1.7) 
 
SCHEME 1.7 GENERAL SCHEME OF PHOTOOXYGENATION OF SUGAR FURANS 
 
 to search new approaches to lignan-like compounds starting from opportunely 
prepared furans 
 to investigate the reactivity towards singlet oxygen of novel furan structures.  
 
  
 
 
 
 
 
 
CHAPTER 2. SYNTHESIS OF GLYCOSYL FURANS 
AND APPLICATIONS IN THE FIELD OF C-
GLYCOSIDES AND C-NUCLEOSIDES 
 
 
 
 
 
 
 
 
 
  
 
2. INTRODUCTION  
Over the years glycosides, due to their importance in natural products 
chemistry,represent a class of molecules widely studied. Considering the nature of the 
glycosidic bond between the anomeric carbon (C-1) and the aglycone it is possible to 
distinguish among O-glycosides, N-glycosides, C-glycosides and S-glycosides. 
The role of glycosides in biological processes is widely known. Of particular interst are 
nucleosides. As known, a nucleoside consists simply of a nucleobase bound to either 
ribose or deoxyribose via beta-glycosidic linkage; nucleosides linked to  a phosphate 
group are the molecular building-blocks of DNA and RNA. Modified nucleosides are 
represented by compounds that differ from the natural analogous for changes in the 
sugar structure. Some derivatives have been used as therapeutic drugs. Compounds 
that act as anti-viral and anti-cancer drugs are Acyclovir (Sawdon and Peng 2013;  
Moustafa et al 2011) or Azidothymidine(FIGURE 2.1) (Radzio and Sluis-Cremer 2008; 
Fischl et al. 1990). 
O
N3
HO N
NH
O
O
H3C
Azidothymidine
N
N
H
H2N
O
N
N
O
HO
Acyclovir  
FIGURE 2.1 STRUCTURE OF ACYCLOVIR AND AZIDOTHIMIDINE 
The first strongly inhibits herpes virus, while the second inhibits the HIV virus.  
There is a further class of modified nucleosides, where the sugar and nucleobases are 
linked through a β-C-glycosidic linkage: the C-nucleosides. These derivatives present a 
carbon-carbon linkageto the anomeric centre and  result particularly stable to chemical 
and enzymatic hydrolysis. In C-nucleosides the sugar moiety is often a ribose or 
deoxyribose and the aglycon part an aryl compound but a variety of other structures 
are also found.They can exhibit biological properties similar to those of their O- and N-
  
 
analogues; some of these molecules exhibit antibacterial, antiviral and antitumour 
properties. An example of natural C-nucleosides is showdomycin (Barrett and 
Broughton 1986; Hungerford et al. 2003) (FIGURE 2.2). 
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FIGURE 2.2 STRUCTURE OF SHOWDOMYCIN  
Showdomycin was isolated in 1964 from Streptomyces Z-452. It shows mild activity 
against Gram-positive and Gram-negative bacteria andit can also stop the growth of 
tumor cells. 
On the basis of these applications it is considered important to develop new molecules 
that can act in a targeted and effective way, whilst minimizing side effects. C-glycosides 
synthesis is difficult (Wellington and Benner 2006; Picard et al. 2006; Chaumontet et 
al.2006; Bililign et al.2005) but the field of synthesis of C-glycosides and C-nucleosides is 
in continuous development due to searching for new molecules as well as for efficient 
and environmentally friendly procedures. 
The common strategy for the synthesis of glycosides involves a nucleophilic attack on 
this naturally electrophilic centre. The activation of the anomeric centre is based on a 
previous reaction which converts the C-1 hydroxyl group in a better leaving group. Over 
the years a great variety of electrophilic sugars have been prepared and employed 
(Postema 1995). Glycosyl halides as chlorides, bromides and fluorides have been used 
extensively in C-glycoside preparation as leaving group with different nucleophiles. 
Another common electrophile is the anomeric O-tricholoacetoimidate that leads to C-
glycosides in good yields. The carbon nucleophiles that have been used as glycosyl 
acceptors include: olefins, silyl enol ethers, silyl cyanide and organometallics such as 
organolithium, aluminates and Grignard reagents. For these electrophilic sugars the 
  
 
products obtained are often α-C-glycosides. This general trend can be explained 
considering that when the sugar electrophile is exposed to Lewis acidic conditions, an 
intermediate oxonium is formed (SCHEME 2.1). Hence, the attack of nucleophile on the 
intermediate is predominantly from the α-face under control of the anomeric effect. 
This method is the most generally used, but sometimes it cannot guarantee good 
results because of the degradation of the selected acceptors due to harsh acidic 
conditions (Postema 1995; Levy and Tang 1995). 
 
SCHEME 2.1 NUCLEOPHILIC ATTACK TO PYRANOOXONIUM INTERMEDIATE 
An interesting approach to achieve β-C-glycosides involves the addition of an 
organometallic reagent to a sugar lactone; the result is normally a mixture of lactols 
which are selectively reduced to the required β-glycosides. 
Considering the relevant biological activity of some natural C-nucleosides, the synthesis 
of these derivatives represents an important field of research. There are several types of 
strategic approaches to synthesise C-nucleosides, that can be divided into two main 
classes. The first involves direct attachment of the base heterocycle to the C-1 carbon of 
the D-ribosugar. The second strategy is less general and involves the conversion of a 
heterocycle precursor, bonded to β-C-riboside, to the target molecule (SCHEME 2.2). So 
in effect, the key point of this approach is the stereoselective synthesis of β-C-ribosides 
bearing a useful carbon fragment. 
 
  
 
SCHEME 2.2 ALTERNATIVE SYNTHETIC GLYCOSYDES ROUTE 
The direct coupling often gives unsuccessful results, for example due to the acid 
conditions that induce isomerizations or degradations of the aglycone moiety.  
The alternative is particularly useful when it allows to prepare a glycosyl precursor 
bearing an aglycone that can undergo a series of elaborations to give a series of 
derivatives (SCHEME 2.3).  
R
R
Sugar Sugar
R1
Sugar
R2
Sugar
R3
Sugar
R4
Sugar
 
SCHEME 2.3 AN ALTERNATIVE FOR GLYCOSYL PRECURSOR 
In this context, in the laboratory where this thesis has been prepared, a strategy has 
been developed and it is based on the easy oxidability of the furan ring. In particular, 
glycosyl furans have been prepared and the dye-sensitized photooxygenation has been 
used as key step in the synthesis of different compounds and, mainly, of glycosyl 1,4-
dienones that in turn have been utilized for a large number of structural elaborations.  
The photooxygenation of glycosyl furans belongs to synthetic strategies to obtain C-
glycosides via a C-glycoside precursor that is subsequently modified through regio- and 
stereoselective reactions to obtain the desired molecule. The procedure was applied to 
substituted furans with monosaccharides to 5 and 6 atoms of carbon and led to 
  
 
interesting results in  the field of the glycoside synthesis (Cermola et al. 2004; Cermola 
et al. 2005; Cermola and Iesce 2006). The methodology was based on the [4+2] 
cycloaddition reaction of singlet oxygen to glycosyl furans as starting point and 
appropriate structural elaborations of the corrisponding endoperoxides. The advantages 
concern the possibility to synthesize different glycosyl derivatives from a single furan 
precursor. Furans with glycosidic residues (pentose and hexose)  in 2 or 3 position were 
prepared and photooxygenated. When the residue of the monosaccharide is linked to 
the starting furan in 2 position, O-glicosides of type A are  formed almost quantitatively 
through a Baeyer-Villiger like-rearrangement which occurs with ritention of  
configuration to the anomeric carbon (SCHEME 2.4). 
Cis-C-glicosides of type B instead can be obtained almost quantitatively through 
reduction of the  crude photooxygenation mixture with Et2S at low temperature (SCHEME 
2.4). 
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SCHEME 2.4 SOME PRODUCTS OF FOSC OF GLYCOSYL FURANS 
 
Interesting results were obtained by photooxygenation conducted on 2,5-
bis(glycosyl)furans (Scheme 2.5)(Cermola et al. 2011). These studies allowed to prepare 
new 1,1'-linked disaccharides separated by a functionalized spacer, structurally related 
to mimetics of Sialyl Lewis X (sLe
x
), a tetrasaccharide involved in inflammatory 
responses (FIGURE 2.3) (Kaila and Thomas 2002; Hiruma et al.1996; Cheng et al. 2000).   
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SCHEME 2.5 PHOTOOXYGENATION OF 2,5-BIS(2',3',4',6'-TETRA-O-BENZYL-D-GLUCOPIRANOSYL)FURAN 
During this study, useful information on the thermal rearrangement of asymmetrical 
2,5-bis(glycosyl)furans was obtained. In particular it was  demonstrated that i) the 
thermal rearrangement trend depends on steric factors and ii) the protecting groups 
can have an important  role in this  process.  
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FIGURE 2.3 SIALYL LEWIS X AND MIMETICS 
 
The use of a ribosyl 1,4-diketone, easily obtained by photooxygenation followed by Et2S 
reduction provided simple procedures for novel pyridazine C-nucleoside C and 
pyrazoline C-nucleoside D (Cermola and Iesce 2006) and new functionalized exo-glycals 
E (Cermola and Iesce 2006) (SCHEME 2.6). 
  
 
 
SCHEME 2.6 SYNTHETIC APPLICATIONS OF FOSC OF RIBOSYL FURANS 
 
In this context part of the PhD work was focused to use opportunely substituted 
glycosyl furans and their corresponding endoperoxides, obtained by dye-sensitized 
photooxygenation, as a possible alternative to common routes to get spiroketals of 
monosaccharides and novel piridazine C-nucleosides. We were inspired by some results 
reported in the literature.  
  
 
2A. ONE-POT PROCEDURE FOR NOVEL SPIROKETALS OF 
MONOSACCHARIDES  
A spyro compound is a bicyclic compound with rings connected via a single  atom, also 
called spiroatom. Although a wide array of ring sizes are possible, the most abundant 
motifs in Nature are [5.6]-, [5.5]- and [6.6] (FIGURE 2A.1). 
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FIGURE 2A.1 EXAMPLE OF SPYROKETALS STRUCTURES 
The interest towards this class of molecules is due to the spiroketal moiety represents a 
privileged substructure since it can be found in many simple or complex natural 
products characterized by important and assorted biological properties, from antibiotic 
to anticancer, as spongistatin 1 (Xu et al. 2011), avermectins (Davis and Green 1991), 
milbemycins (Wang et al. 2011).  
The synthetic approaches to obtain spiroketals are manifold. The most common 
methods involve the use of oxo-diols as precursors and  spiro-cyclizations are subjected 
to acid-catalyzed in the presence of Lewis or Bronsted acids (SCHEME 2A.1) (Venkatesh 
and Reissig 2008; Castagnolo et al. 2007; Crimmins and O’Mahony 1989). 
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SCHEME 2A.1  SYNTHESIS OF SPYROKETALS BY RING  CLOSURE OF OXO DIOLS 
 
Interesting applications of the traditional method employ Achmatowicz reaction. As 
above reported, oxidation of a furan system with an oxidising agent, as m-CPBA, PCC, 
TBHP or with NBS leads to a 1,4-dicarbonylic compound. When the starting furan is a 
hydroxyalkyl furan, the oxidation leads to a α-hydroxy-1,4-dicarbonyl compound, that 
cyclizes spontaneously into a functionalized pyranone (Achmatowicz 1981)(SCHEME 
  
 
2A.2). 
 
SCHEME  2A.2 GENERAL MECHANISM OF ACHMATOWICZ REACTION 
 
So, spiroketals I e L are obtained via acid-catalyzed cyclization of piranone H, in turn 
obtained by oxidation with m-chloroperbenzoic acid of the appropriately protected 
furyldiol F (SCHEME 2A.3). 
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SCHEME 2A.3 SYNTHESISOF SPIROKETALS VIA  ACHMATOWICZ REACTION 
The procedure was used for the preparation of functionalized spiro compounds. Their  
structural elaboration provided important informations in the field of antibiotics family 
for istance avermectine (Achmatowicz  1981). 
As useful alternative to the oxidation with peracids, recently  spiroketals were obtained 
starting from  2,5-dihydroxyalkylfurans via a dye-sensitized photooxygenation followed 
by reduction with Et2S and acid catalyzed cycloaddition (SCHEME 2A. 4) (Montagnon et al 
2008).  
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SCHEME 2A.4  SYNTHESIS OF [5,4,5]-BIS-SPIROKETALS 
In both cases  (SCHEME 2A.3 and SCHEME 2A.4) the  reactive intermediate is an enedione 
obtained by different routes. The photooxygenation followed by reduction presents 
numerous advantages respect to the oxidation with peracids or other oxidizing agents, 
due to the use of environmentally friendly oxygen, mild reaction conditions, dyes,  and 
generally it leads to higher yields.  
On the basis of these considerations the research was focused to synthetize novel 
spiroketals of monosaccharides using the following approach:  
 
 
SCHEME 2A.5 RETROSYNTHESIS FOR [5,4,5]-BIS-SPIROKETALS 
 
Glycosyl derivatives as 2a were envisaged as suitably substituted starting furans; the 
synthetic approach to be used was reported in the literature for 2a and utilizes a 
glucolactone as 1a and furyllithium (Czernecki and Ville 1989) (SCHEME 2A.6). 
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SCHEME 2A.6  SYNTHETIC APPROACH FOR SUGAR FURAN 2a  
  
 
RESULTS AND DISCUSSION:  
Synthesis of Glycosyl Furans 2 
Starting 2,3,4,6-O-tetrabenzyl-D-glucono-1,5-lactone 1a was obtained by Swern 
oxidation of commercially available 2,3,4,6-O-tetrabenzyl-D-glucopyranose (Overkleeft 
et al. 1994) (SCHEME 2A.7). 
 
SCHEME 2A.7  SWERN OXIDATION 
Lactone 1a was isolated by silica gel chromatography in 95 % yield and was identified by 
comparison with literature data (Overkleeft et al. 1994). 
2-Furyllithium was prepared by adding n-butyllithium to a solution of furan in dry 
tetrahydrofuran (THF) at 0° C and stirring the resulting solution for 4h at room 
temperature (SCHEME 2A.8). 
 
 
SCHEME 2A.8 2-FURYLLITHIUM PREPARATION 
Coupling reaction between 2-furyllithium and lactone 1a afforded compound 2a (60 %), 
together with an unreported product to which, on the basis of spectroscopic NMR data 
and by comparison with literature data (Rosenblum and Bihovsky 1990), the structure 
of α,β-unsaturated lactone 1a’ was assigned (SCHEME 2A.9). 
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SCHEME 2A.9 COUPLING REACTION BETWEEN 1a AND 2-FURYLLITHIUM 
  
 
Formation of 1a’ was rationalised through an elimination side-reaction of a benzyl 
protecting group due to the basic behaviour of 2-furyllithium. Elimination of the benzyl 
protecting group is reported in the literature by using different metal bases (Rosenblum 
and Bihovsky 1990). 
The synthetic method was then applied to commercially available 2,3,5-tri-O-benzyl-D-
ribono-1,4-lactone 1b. Coupling reaction with 2-furyllithium afforded the open chain 
form 2’b (58%) as evidenced by 
13
C NMR spectrum that showed the presence of a signal 
at 187.6 ppm, a typical value of a ketone function.  Only a very little amount of the 
isomeric ring structure 2b was present at the equilibrium, as evidenced by 
1
H NMR 
spectrum. Silica gel chromatography afforded, as previously observed in the synthesis of 
2a, the corresponding unsaturated sugar 1b’, which was identified by comparison of its 
spectral and physical data (mp 82°C) with those reported in literature (Csuk et al.1997) 
(SCHEME 2A.10). 
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SCHEME 2A.10 SYNTHESIS OF KETAL 2b 
Subsequently, lactone 1b was coupled with 3-furyllithium. The latter was prepared by 
halogen-metal exchange process from commercially available 3-bromofuran and n-
butyllithium, as shown in SCHEME 2A.11. 
 
SCHEME 2A.11 HALOGEN-METAL EXCHANGE PROCESS FOR 3-FURYLLITHIUM PREPARATION 
  
 
The coupling reaction was conducted at -78°C to prevent the rearrangement of 3-
furyllithium to the thermodinamically more stable 2-furyllithium which starts at 
temperature over -40°C. Also in this case, the ketal 2’c was isolated after silica gel 
chromatography (50% yield) along with elimination product 1b’ (SCHEME 2A.12). The 
acyclic structure was assigned on the basis of 
1
H and 
13
C NMR data.  
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SCHEME 2A.12 SYNTHESIS OF THE KETAL 2’c 
 
Dye-Sensitized Photooxygenation of Furans 2a-2c and Et2S reduction 
The photooxygenation reactions of furan 2a was carried out -60°C using dry 
dichloromethane in the presence of methylene blue as the sensitizer. The solution was 
irradiated with a halogen lamp while dry oxygen was bubbling through the solution. 
When the reaction was complete (TLC), 2 equiv. of Et2S were added at -60°C. The 
mixture was maintained at -60°C for 120 min and then kept at  -25 °C overnight. The day 
after the crude reaction was placed at r. t. and the solvent and the excess of sulfide 
were removed at reduced pressure. A rapid chromatography on silica gel afforded a 
partial separation of the two products to which, on the basis of mono- and bi-
dimensional NMR spectra, structures 6a and 6'a were assigned (SCHEME 2A.13). 
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                                                               SCHEME 2A.13 FOSC AND REDUCTION TREATMENT OF 2a 
 
It is to be noted that the 
1
H NMR analysis of the residue in CDCl3 showed the presence 
of two products, in an initial molar ratio of about 1:5 (FIGURE 2A.2). They were in 
equilibrium and after 2 days the molar ratio was almost inverted (2:1) (FIGURE 2A.3). 
 
FIGURE 2A.2 EXPANDED 
1
H NMR (CDCl3) OF THE CRUDE PHOTOOXYGENATED CH2Cl2 SOLUTION OF 2a 
 
 
 
 
  
 
 
 
 
 
 
 
 
FIGURE 2A.3 EXPANDED
1
H NMR  OF THE CRUDE PHOTOOXYGENATED MIXTURE OF 2a AFTER 48h  
 
The configuration  at the C- 2 of both diastereoisomers 6a and  6'a was tentatively 
assigned on the basis of thermodynamic considerations. As reported in the literature, 
an arrangement with both oxygens in an axial position represents a situation of 
maximum stability conferred by a double anomeric effect (Venkatesh and Reisseg 2008; 
Castagnolo et al. 2007; Crimmins and o’Mahony 1989; Deslongchamps 1983; Kirby 
1983; Juaristi and Cuevas 1995) (FIGURE 2A.4). 
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FIGURE 2A.4 POSSIBLE CONFIGURATIONS OF  [6.6] SPIROKETALS 
The formation of two diastereoisomeric spiro compounds is justified since the attack of 
the hydroxyl group to the aldehydic carbon of the enedione 5a can take place from both 
sides of the plane of the unsaturated system, thus generating both configurations 
(SCHEME 2A.13). 
The assignment  of diastereomeric structures at the C-2  was confirmed  by carrying out 
  
 
a Swern oxidation on a chromatographic fraction containing the two isomers in the 
molar ratio of ca 1:1. The reaction led quantitatively to the expected glycosyl derivative 
7a, which was isolated and characterized spectroscopically (SCHEME 2A.14). 
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SCHEME 2A.14 SWERN OXIDATION OF THE MIXTURE OF 6a AND 6'a 
FIGURE 2A.5 and FIGURE 2A.6 show the 
1
H NMR spectra of the mixture of 6a and 6'a 
before and after oxidation. Comparison of the two spectra evidenced the disappearance 
of the signals of the H-2 protons and the conversion of the signals relative to the 
protons of the unsaturated system of both diastereoisomers to signals corresponding to 
a single system CH=CH present in the derivative 7a. 
 
FIGURE 2A.5 
1
H NMR (CDCl3) OF THE MIXTURE OF 6a AND 6’a USED FOR THE SWERN OXIDATION 
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FIGURE 2A.6.5 EXPANDED 
1
H NMR  OF DERIVATE 7a 
Noesy experiments allowed to assign the structure 6a with the (R)-configuration at the 
new stereocenter (C-2) to the more stable derivative which was the main product at the 
equilibrium. These experiments also validated the -configuration at the sugar-ring of 
both spiroketals, that is probably ensured by a thermodynamic control since two 
anomeric effects are in operation in a diaxial arrangement (Deslongchamps 1983), as 
previously reported in similar cases (FIGURE 2A.7). 
 
 
 
FIGURE 2A.7 NOE EFFECT BETWEEN H-2 AND H-3’ 
In particular, there was a strong NOE effect between H-2 and H-3' protons  of spiro ketal 
isomer present in higher amount at the equilibrium at r.t. (hence the 
thermodynamically more stable isomer), thus indicating for this compound structure 
6a. Theoretical calculations*performed on both diastereoisomers were in agreement 
with the results of NOESY experiments suggesting that spiroketal 6a is stabilized by an 
intramolecular hydrogen bond between the new OH group at C-2  and the sugar-ring 
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oxygen, which is not feasible for 6a’ (FIGURE 2A.8). Calculations found that (2R)-6a is 
more stable than (2S)-6’a of 3.7 kcal/mol. 
FIGURE 2A.8 HYDROGEN BOND IN SPIRO 6a 
The synthesis of spiro ketals 6a and 6’a can be carried out in a one-pot route  with total 
yield 80% as follows: 
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SCHEME 2A.15 ONE-POT SYNTHESIS OF SPIROKETALA 6a AND 6’a 
Despite the open form, we decided to use also the ribofuranosyl furan 2’b, that was 
photooxygenated and reduced as 2a. After removal of the solvent under reduced 
pressure, the residue was analyzed by NMR spectroscopy showing the formation of two 
diastereomeric products that were obtained in 68%  total yield.  
*Theoretical calculations were performed by SSPARTAN '08 Quantum Mechanics Program. The geometric 
optimizations (method: HF/3-21G) were performed starting from minimized conformers (conformational 
analysis by MMFF-molecular mechanics). Energies were calculated running single points by B3LYP/6.31G* 
method. 
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SCHEME 2A.16 ONE-POT SYNTHESIS OF SPIROKETALA 6b AND 6’b 
The proton spectrum immediately after solvent removal (FIGURE 2A.9) shows the 
presence of the two products in a molar ratio of 1:7 with a pattern of signals of a system 
CH=CH-CH-O in the range 5.5-7.0, similar to that observed for spiroketals 6a and 6'a. 
 
 
 
 
 
FIGURE 2A.9 EXPANDED 
1
HNMR OF 6b  AND 6’b 
Also in this case the ratio of the two products changed over time and after 12h they 
were present approximately in the molar ratio of ca 5:1 (FIGURE 2A.10). 
 
  
 
 
FIGURE 2D.10HNMR SPECTRUM OF 6b and 6’b AFTER 12 h IN CDCl3 
To these compounds mono- and bi-dimensional spectral data allowed to assign 
structures 6b and 6'b, reported in SCHEME 2A.16. 
 
Although the cycloaddition reaction of 
1
O2 occurred on acyclic derivative 2’b, it is likely 
that the enedione 5’b obtained by reduction in situ of the corresponding endoperoxide 
4’b undergoes a double cyclizations as follows: 
 
 
 
 
SCHEME 2A.17 DOUBLE CYCLIZATION OF THE ENEDIONE 5’b 
Unfortunately, NOESY experiments conducted to  assign configurations to the new chiral 
center C-2, failed. However, the structure 6b was tentatively assigned to the 
diastereoisomer present as the main product at the equilibrium on the basis of 
theoretical calculations* performed  on both stereoisomers. These calculations found a 
lower energy for 6b than for 6’b of 2.3 kcal/mol.  As observed for 6a, the calculated 
structure for 6b showed the presence of an intramolecular hydrogen bond between the 
OH and the sugar-ring oxygen.  
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Finally, the procedure was applied to the sugar-furan 2’c. As expected, the complete 
stereoselectivity of the reduction pathway provided the ,-unsaturated compound 5c, 
which presents an unsuitable configuration for cyclization. Anyway, silica gel 
chromatography promoted an acid-catalyzed isomerization into the enedione 5’c which 
quickly cyclized into the new spiroketals 6c and 6’c (molar ratio 1:2, overall yields 25%) 
(SCHEME 2A.18). 
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SCHEME 2A.18  SYNTHESIS OF 6c AND 6’c 
Also in this case NOESY experiments have not allowed to assign the configuration to the 
two diastereoisomers. As suggested by theoretical calculation*, to the main product the 
structure (2S)-6’c was tentatively assigned which was more stable than (2R)-6c of 2.4 
Kcal/mol and showed a hydrogen bond between the -OH at C-2 and the oxygen at C-2’ 
of the sugar ring* as already observed for 6a/6’a and 6b/6’b. 
 
 
 
 
 
 
 
*Theoretical calculations were performed by SSPARTAN '08 Quantum Mechanics Program. The geometric 
optimizations (method: HF/3-21G) were performed starting from minimized conformers (conformational 
analysis by MMFF-molecular mechanics). Energies were calculated running single points by B3LYP/6.31G* 
method. 
  
 
2B.  ONE-POT PROCEDURE FOR 1,2-PYRIDAZINE C-NUCLEOSIDES 
RESULTS AND DISCUSSION: 
The nucleoside nature of ribofuranosyl furans 2b and 2c induced us to explore further 
applications of sugar furans and the dye-sensitized photooxygenation in order to obtain 
novel C-nucleosides, in particular novel pyridazine C-nucleosides less substituted than 
previous reported  compound (Cermola and Iesce 2006).  For this purpose the suitable 
novel furans 3 were prepared. 
 
 
 
Preparation of starting -Glycosyl Furans 3 
The procedure employed was a stereoselective reduction of furans 2 with triethylsilane 
(Et3SiH) and boron trifluoride diethyl etherate (BF3
.
Et2O) as promoter that was 
previously described for furan 2a (Czernecki and Ville 1989).   
To verify the feasibility, the reduction was firstly performed starting from 2a by using 
the reagents under stirring at -40 °C for 1h (SCHEME 2B. 1). The resulting C-glycoside -3a 
was isolated in 64% yield and identified by comparison with NMR data reported in 
literature(Czernecki et al.1989). 
 
 
SCHEME 2B.1 SYNTHESIS OF3a 
The stereoselective step of this route leads only to β-glicoside, and this should be due to 
the anomeric effect that stabilizes the carbocationic intermediate, favouring hydride 
  
 
attack at α-face (FIGURE 2B. 1). 
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FIGURE 2B.1 CARBOCATIONIC INTERMEDIATE STABILIZED BY ANOMERIC EFFECT 
Reduction of 2b/2’b was conducted in the same condition as above reported for 2a but 
required a longer reaction time (4h at -40°C and overnight at rt) owing to the main 
presence of the open-chain product 2b’ (SCHEME 2B.2). 
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SCHEME 2B. 2 SYNTHESIS OF GLYCOSYL FURAN -3b 
Although the 
1
H-NMR spectrum of the crude reaction mixture showed the presence of 
the only product-3b (FIGURE 2B.2), considerable loss of material occurred during 
chromatography, according to literature data (Macdonald et al. 1988). Compound -3b 
was isolated by silica gel flash chromatography in 35% yield. 
  
 
 
FIGURE 2B. 2  
1
H NMR OF THE CRUDE REACTION MIXTURE OF -3b 
The 2-(β-ribofuranosyl)furan -3b was fully characterized by mono- and bidimensional 
NMR data and, in particular, the β stereochemistry at C-1 was confirmed by NOESY 
experiment which evidenced the cis spatial relationship between H-1’ and H-4’ protons 
(FIGURE 2B. 3). 
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FIGURE 2B.3 NOE EFFECT BETWEEN H-1’ AND H-4’ 
Subsequently, the same procedure was used to obtain 3-(ribofuranosyl) furan -3c that 
was recovered by chromatography in low yield (30% yield) likely due to considerable 
loss of product by the adsorbent, as experimented for  -3b (SCHEME 2B.3).  
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SCHEME 2B. 3 SYNTHESIS OF GLYCOSYL FURAN -3c 
 
The β-configuration was assigned by NOESY experiment that showed NOE effect 
between H-1’ and H-4’ (FIGURE 2B.4). 
 
 
FIGURE 2B.4 NOE EFFECT BETWEEN H-1’ AND H-4’ 
Synthesis of 1,2-Pyridazine C-Nucleosides 
The 2-(β-ribofuranosyl)furan -3b was photooxygenated as described before. When the 
photooxygenation was complete (TLC), 2 equiv. of Et2S were added at -40 °C. The 
mixture was maintained at -40°C for 120 min and then was kept at  -25 °C overnight. 
The low temperature was needed because endoperoxides of 2-(glycosyl)furans are 
thermally unstable and rearrange rapidly from C- to O-glycosides (Cermola et al. 2004, 
2005). Then, the 
1
H NMR experiment of an aliquot of the mixture showed the α,β-
unsaturated-1,4-dicarbonyl glycoside -9b. This was unstable in CDCl3 and isomerized 
into more stable trans-isomer -9b’ (SCHEME 2B.4). Attempts to purify both cis--9b and 
trans--9b’ failed since they give only polymeric material by chromatography. 
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SCHEME 2B.4 ENDOPEROXIDES -8b REDUCTION 
Attempt to employ the previous procedure (addition of hydrazine chloridrate to a 
methanolic solution of the crude enone as previously reported (Cermola and Iesce 
2006) failed evidently due to conformationally unstability of compound -9b that which 
rapidly isomerized into trans-isomer -9b’ that is inadeguate to cyclize with hydrazine. 
The expected 3-(β-ribofuranosyl)-pyridazine -10b was however obtained by addition to 
the crude reduction mixture of a 2M hydrazine solution in THF (SCHEME 2B.5). 
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SCHEME 2B.5 ONE-POT SYNTHESIS OF PYRIDAZINE -10b 
The 
1
H NMR spectrum showed the presence of only one product that was purified by 
silica gel chromatography. To this product mono- and two-dimensional NMR studies 
  
 
assigned the 3-(β-ribofuranosyl)-pyridazine structure-10b. The β-configuration at C-1’ 
was confirmed by NOESY experiments which evidenced a cis-spacial correlation 
between the H-1’ and the H-4’ of the sugar ring. Finally, the synthesis of 10b was 
realized through a one-pot procedure, as shown in SCHEME 2B.5. 
The one-pot procedure was then applied to 3-(β-ribofuranosyl)furan -3c. In this case 
the photooxygenation was performed at -20°C owing to higher stability of the 
corresponding endoperoxide. The reaction was checked by TLC and it was complete 
after approximately 90 min. Then 2 equiv. of Et2S were added and the mixture was kept 
at -20 °C overnight. The 
1
H NMR spectrum of the crude mixture showed the presence of 
the glycosyl enedione -9c. In contrast to enedione -9b, this was configurationally 
stable. Cyclization by addition to the crude -9c, of a 2M hydrazine solution in THF 
(SCHEME 2B.6). led to the corresponding 4-(β-ribofuranosyl)pyridazine -10c that was 
characterized by mono- and bidimensional NMR spectroscopy. The β-configuration at  
C-1’ was confirmed by NOESY experiments. 
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SCHEME 2B.6 ONE-POT SYNTHESIS OF PYRIDAZINE -10c 
 
 
  
 
2C.  CONCLUSION 
In this part of the work two interesting  applications of furans have been pointed out in 
the field of C-glycosides and C-nucleosides. In particular, a one-pot synthetic procedure 
for novel spiroketals of monosaccharides has been developed starting from suitably 
prepared glycosyl furans using the photooxygenation as a key reaction.  
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SCHEME 2C.1 ONE-POT SYNTHESIS OF SPIROKETALS OF MONOSACCHARIDES 
 
The procedure has led successfully to novel spiroketals of  monosaccharides with [5.5], 
[6.5] and [6.6] structtures. These structures are among the most widespread in nature, 
often present in many bioactive derivates. The method represents a valid alternative, 
for the good yields and the mild reaction conditions, to other methods reported in the 
literature that require acidic oxidation conditions or the use of organometallic 
compounds. The novel spiroketals are highly functionalized in the aglyconic part and are 
susceptible to further reactions suggesting the possibility of expanding the number of 
spiroketals of pharmacological interest obtainable starting from one glycosyl furan.  
Noteworthy are the novel -ribofuranosyl furans 3b and 3c, that by photooxygenation 
followed by reduction of the corresponding endoperoxides afford 1,4-dicarbonyl--
unsaturated derivatives which have been tested in cyclization with hydrazine. The latter 
reaction provides novel pyridazine C-nucleosides -10 for which a one-pot procedure 
has been developed (FIGURE 2C.1) . The interest for these derivatives is due to the 
pyridazine nucleus and its 3-oxo derivatives have been recognized as versatile 
pharmacophores (Elnagdi et al. 2009). This key subunit is constituted in many 
biologically active substances with a broad range of biological and pharmaceutical 
  
 
activities including antibacterial and antifungal activities, 5-lipoxygenase inhibitors and 
inhibitors of interleukin 1 beta-production.  
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FIGURE 2C.1 PYRIDAZINE C-NUCLEOSIDES -10 SYNTHETIZED 
 
 
 
 
 
 
 
 
 
 
 
  
 
2D.  EXPERIMENTAL SECTION  
Material and Methods: Nuclear magnetic resonance (NMR) spectra were recorded 
at 500 MHz for [1H] and 125 MHz for [13C] on a Fourier Transform NMR Varian 500 Unity 
Inova spectrometer. The carbon multiplicity was evidenced by DEPT experiments. The 
proton couplings were evidenced by 1H-1H COSY experiments. The heteronuclear 
chemical shift correlations were determined by HMQC (optimized for 
1
JHC,140 Hz) and 
HMBC (optimized for 
1
JHC,8 Hz) pulse sequences. 
1H–1H proximities through space 
within a molecule were determined by NOESY. Analytical TLC was performed on 
precoated silica gel plates (Macherey-Nagel) with 0.2 mm film thickness. Spots were 
visualized by UV light and by spraying with EtOH-H2SO4 (95:5) followed by heating for 5 
min at 110 °C. Column chromatography was performed on silica gel (Macherey-Nagel). 
Furan (Aldrich), 3-bromofuran (Aldrich), acetic anhydride (Aldrich), dry 
dimethylsulfoxide (DMSO) (Aldrich), 2,3,4,6-tetra-O-benzyl-D-glucopyranose (Aldrich), 
2,3,5-tri-O-benzyl-D-ribono-1,4-lactone (Carbosynth), 1.6 M n-BuLi solution in hexane 
(Aldrich), dry tetrahydorfuran (THF) (Aldrich), diethyl sulfide (Aldrich), triethylsilane 
(Aldrich) and the etherate boron trifluoride (BF3
.
Et2O) (Fluka) were commercially 
available. 
General procedure of  the dye-sensitized photooxygenation:  A 0.02 M 
solution of starting furan (0.25mmol) in dry CH2Cl2 was irradiated  at the appropriate 
temperature with a halogen lamp (650 W) in the presence of methylene blue as 
sensitizer (MB, 1x10
-3
 mmol), while dry oxygen was bubbled through the solution. The 
progress of each reaction was checked by periodically monitoring the disappearance of 
furan by TLC, or by 
1
H NMR spectroscopy. 
 
Experimental-Part 2A  
Synthesis of lactone 1a:  540 mg (1mmol) of 2,3,4,6-tetra-O-benzyl-D-
glucopyranose was dissolved in dry DMSO (2.7mL). Then, acetic anhydride (1.6mL) was 
added and the resulting solution was stirred at r.t. under argon atmosphere. After ca 12 
h the reaction was quenched by adding H2O (ca. 10 mL). The organic layer was extracted 
  
 
with CHCl3, washed with H2O (5 x 10mL), dried on Na2SO4 and filtered. Then, the solvent 
was removed under reduced pressure and the residue was chromatographed on silica 
gel (n-hexane/ethyl acetate 7:3 v/v) affording lactone 1a (Overkleeft et al.1994) as oil in 
95 % yield. 
 
2-Furyllithium: To a solution of furan (68 mg, 1mmol) in dry THF (1.5mL), n-BuLi 
hexane solution 1.6M (0.75mL, 1.2mmol) was added at 0°C. The reaction mixture was 
stirred at r.t. for 4 h under argon atmosphere before use. 
Synthesis of 2a: Lactone 1a (1.08 g, 2mmol) was dissolved in 5 mL of dry THF, and 
the resulting solution was cooled to -50°C under argon. A fresh 2-furyllithium solution 
was then added, and the mixture was stirred for 4 h at -50°C. The temperature was then 
allowed to rise to r.t. while the mixture was further stirred overnight. Then, the reaction 
was quenched by adding a NH4Cl saturated aqueous solution. The organic layer was 
extracted with ether, drying over Na2SO4 and filtered, the solvent was evaporated under 
reduce pressure. The crude was chromatographed on silica gel (n-hexane/ethyl acetate 
7:3 v/v) yielding 2a (60 % yield)as yellow oil (Cermola et al.2014). 
 
2a: oil; 
1
H NMR (CDCl3)3.70-3.84 (m, 3H, H-6’A, H-6’B and H-5’), 3.92 (d, 1 H, J= 7.5 Hz, 
H-2’), 4.02 (dd, 1H, J= 6.0, 3.2 Hz, H-4’), 4.06 (dd, 1H, J= 7.5, 3.2 Hz, H-3’), 4.48  (d, 1H, 
J= 10.5Hz, CH of Bn), 4.52 (d, 1 H, J= 10.8 Hz, CH of Bn), 4.61 (d, 1 H, J= 8.5 Hz, CH of 
Bn), 4.63 (d, 1 H, J= 10.5 Hz, CH of Bn), 4.69 (s, 2 H, CH2 of Bn), 4.85 (d, 1H, J= 10.8 Hz, 
CH of Bn), 4.89 (d, 1H, J= 8.5 Hz, CH of Bn), 6.41 (dd, 1H, J=3.5, 1.9 Hz, H-4), 6.56 (d, 1 
H, J= 3.5Hz, H-3), 7.21-7.42 (m, 20H, 4 x Ph), 7.43 (d, 1H, J= 1.9Hz, H-5); 
13
C NMR  
68.6 (t), 72.3 (d), 73.3 (t), 74.9 (t), 75.0 (d), 75.6 (t), 77.9 (d), 82.5 (t), 82.9 (d), 94.8 (s), 
108.2 (d), 110.6 (d), 127.5 (d), 127.7 (d), 127.8 (d), 127.9 (d), 128.2 (d), 128.3 (d), 
128.4 (d), 137.5 (s), 138.2 (s), 138.3 (s), 138.6 (s), 142.4 (d), 153.8 (s). 
  
 
Synthesis of 2’b: furyllithium solution kept at -60°C, lactone 1b(418mg, 1mmol) 
previously dissolved in 2.4mL of dry THF was added and the resulting mixture was 
stirred under argon athmosphere at -60°C for 4h. Then the temperature was allowed to 
rise to r.t. while the mixture was further stirred overnight. Then, the reaction was 
quenched by adding a saturated aqueous solution of NH4Cl. The organic layer was 
extracted with ether (3x30mL), drying over Na2SO4 and filtered, the solvent was 
evaporated under reduce pressure. The crude was chromatographed on silica gel (n-
hexane/ether 1:1 v/v) yielding 2b(58% yield) as yellow oil (Cermola et al. 2014). 
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2b: oil; IR (CHCl3)  3432, 1680, 1600, 1173 cm
-1
; 
1
H NMR (CDCl3)3.62 (m, 2H, H-5’AB), 
4.06 (dd, J= 6.6, 4.9Hz, 1H, H-3’), 4.10 (m, 1H, H-4’), 4.50-4.54 (m, 5H, OH and CH2 of 
Bn), 4.59 (d, J= 11.5 Hz, 1H, CH of Bn), 4.70 (d, J= 11.5Hz, 1H, CH of Bn), 4.82 (d, J= 4.9 
Hz, 1H, H-2’), 6.49 (dd, J= 3.3, 1.3Hz, 1H, H-4), 7.08-7.34 (m, 15H, 3 x Ph), 7.35 (d, J= 3.3 
Hz, 1H, H-3), 7.59 (d, J= 1.3 Hz, 1H, H-5); 
13
C NMR (CDCl3)  70.5 (d), 70.7 (t), 72.8 (t), 
73.4 (t), 80.5 (d), 81.6 (d), 112.2 (d), 119.7 (d), 127.6 (d), 127.8 (d), 128.0 (d), 128.1 (d), 
128.2 (d), 128.3 (d), 128.4 (d), 137.1 (s), 137.5 (s), 138.0 (s), 146.8  (d), 151.9 (s), 187.6 
(s); Anal. calcd. for C30H30O6: C, 74.06; H, 6.21. Found: C, 74.01; H, 6.02. 
3-Furyllithium: A solution of 3-bromofuran (146mg, 1mmol) in dry THF (1.5 mL) was 
kept at -78°C. After 10 min a n-BuLi 1.6 M solution (0.75mL, 1.2mmol) was added and 
the resulting solution was stirred at -78°C for 4 h under argon atmosphere before use. 
 
Synthesis of 2c : 3-Furyllithium solution kept at -78°C, lactone 1b (418mg, 1mmol) 
previously dissolved in 2.4mL of dry THF was added and the resulting mixture was 
stirred under argon atmosphere at -60°C for 4h. Then the temperature was allowed to 
rise to r.t. while the mixture was further stirred overnight. Then, the reaction was 
quenched by adding a saturated aqueous solution of NH4Cl (10mL). The organic layer 
  
 
was extracted with ether (3x30mL), drying over Na2SO4 and filtered, then the solvent 
was evaporated under reduced pressure. The crude was chromatographed on silica gel 
(n-hexane/ether 7:3 v/v) yielding 2c(50 % yield)as yellow oil(Cermola et al.2014). 
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2’c: oil; IR (CHCl3) 3416, 1685, 1601, 1180 cm
-1
;
1
H NMR(CDCl3) 2.66 (d, J= 4.9 Hz, 1H, 
OH), 3.60 (m, 2H, H-5’AB), 4.03 (m, 2H, H-3’ and H-4’), 4.45-4.70 (m, 7H, H-2’ and CH of 
Bn), 6.84 (d, J= 1.1 Hz, 1H, H-4), 7.10-7.33 (m, 15H, 3xPh), 7.38 (d, J= 1.1Hz, 1H, H-5), 
8.23 (s, 1H, H-2);
13
C NMR (CDCl3)  70.2 (d), 70.6 (t), 73.2 (t), 73.4 (t), 73.6 ( d), 81.1 (d), 
84.4 (d) 109.2 (d), 125.8 (s), 127.7 (d), 127.8 (d), 127.9 (d), 128.1 (d), 128.2 (d), 128.3 
(d), 128.4 (d), 128.5 (d), 137.0 (s), 137.5 (s), 137.9 (s), 143.1  (d), 149.3 (d), 195.3 (s); 
Anal. calcd. for C30H30O6: C, 74.06; H, 6.21. Found: C, 73.90; H, 6.08. 
Fosc of furans 2 followed by reduction   
Synthesis of  spiroketals 6a and 6’a: A 0.02M solution of 2a in dry CH2Cl2 was 
irradiated at -60°C with a halogen  lamp (650W) in the  presence of methylene blue as 
sensitizer sensitizer (MB, 1x10
-3
mmol), while dry oxygen was bubbled through the 
solution. The progress of each reaction was checked by periodically monitoring the 
disappearance of furan by TLC. When the photooxygenation reaction was complete (ca. 
90 min), 2 equiv. of Et2S was added to the crude solution at -60°C. After 2h the crude 
solution was kept at -25°C overnight. Then, the solvent and the Et2S excess were 
removed under reduced pressure,  and the silica gel chromatography (n-hexane/ethyl 
acetate 7/:3 v/v) afforded spiroketals 6a and 6’a with 80% yield. 
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6a: oil; 
1
H NMR (CDCl3)  = 3.68(m, 3H, H-6’A, H-6’B e H-4), 3.85 (d, J= 10.8Hz, 1H, OH), 
4.04-4.17 (m, 3H, H-2’, H-3’ e H-5’), 4.47-4.57 (m, 4H, CH2 del Bn), 4.79 (d, J= 10.4 Hz, 1 
H, CH del Bn), 4.84 (d, J= 10.9Hz, 1H, CH del Bn), 4.90 (s, 2H, CH2 del Bn), 5.65 (bd, J= 
10.8Hz, 1H, H-2), 6.19 (dd, J= 10.4, 1.2Hz, 1H, H-4), 6.87 (dd, J= 10.4, 1.6Hz, 1H, H-3), 
7.15-7.38 (m, 20H, 4xPh); 
13
C NMR (CDCl3)  = 68.5 (t), 73.4 (t), 74.0 (t), 75.0 (d), 75.7 
(t), 75.9 (t), 78.0 (d), 79.5 (d), 82.6 (d), 87.7 (d), 98.3 (s), 127.0 (d), 127.7 (d), 127.8 (d), 
128.0 (d), 128.3 (d), 128.4 (d), 137.3 (s), 137.9 (s), 138.1 (s), 138.4 (s), 147.9 (d), 188.6 
(s). 
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6’a: oil; 
1
H NMR (CDCl3)  = 3.36 (t, J= 9.3 Hz, 1H, H-6A’), 3.41 (dd, J=10.4, 9.3Hz, 1H, H-
4’), 3.71 (dd, J= 9.3, 1.6Hz, 1H, H-6B’), 4.09 (m, 2H, H-3’ e OH), 4.27 (d, J= 9.8 Hz, 1H, H-
2’), 4.48 (s, 2H, CH2 del Bn), 4.50 (d, J= 11.5Hz, 1H, CH del Bn), 4.55 (m, 1H, H-5’), 4.63 
(d, J= 10.9Hz, 1H, CH del Bn), 4.78 (d, J= 10.9Hz, 1H, CH del Bn), 4.83 (d, J= 10.9 Hz, 1 
H, CH del Bn), 4.90 (m, 2H, CH2 del Bn), 5.58 (dd, J=12.7, 3.3Hz, 1H, H-2), 6.18 (d, J= 
10.3Hz, 1H, H-4), 6.92 (dd, J=10.3, 3.3Hz, 1H, H-3), 7.15-7.38 (m, 20H, 4xPh); 
13
C NMR 
(CDCl3) =69.1 (t), 71.9 (d), 73.4 (t), 75.0 (t), 75.5 (t), 75.8 (t), 78.4 (d), 78.5 (d), 83.2 
(d), 88.8 (d), 97.7 (s), 124.8 (d), 127.7 (d), 127.8 (d), 127.9 (d), 128.0 (d), 128.2 (d), 
128.4 (d), 137.4 (s), 137.7 (s), 138.0 (s), 138.4 (s), 145.7 (d), 188.7 (s). 
Synthesis of  spiroketals 6b and 6’b: A 0.02 M solution of 2b in 25mL di CH2Cl2 
anidro was photooxygenated as reported for furan 2a. When the photooxygenation 
reaction was complete (ca. 90 min), 2 equiv. of Et2S was added to the crude solution at -
60°C. After 2 h the crude solution was kept at -25°C overnight. Then, the solvent and 
the Et2S excess were removed under reduced pressure, and the silica gel 
chromatography (n-hexane/ethyl acetate 3/:7 v/v) afforded spiroketal 6b  and a fraction 
with  6’b in mixture with 6b(ca 2:1) . Yiels 68 %  
  
 
6b (in mixture with 6’b in ca. 1:1 molar ratio) :
1
H NMR(CDCl3) (selected signals) 4.26 
(bs, 1H, OH), 5.72 (d, J= 2.7 Hz,1H, H-2), 6.18 (d, J= 10.4, 1H, H-4), 6.88 (dd, J= 10.4, 
2.7Hz, 1H, H-3); 
13
C NMR (CDCl3) (selected signals)  69.6 (t), 72.5 (t), 73.0 (t), 73.4 (t), 
76.5 (d), 77.3 (d), 83.7 (d), 88.8 (d), 101.8 (s), 125.6 (d), 127.6 (d), 127.8 (d), 127.9 (d), 
128.0 (d), 128.3 (d), 128.4 (d), 137.5 (s), 137.7 (s), 137.8 (s), 146.3 (d), 188.4 (s). 
6’b: IR (CHCl3) 3420, 1693, 1645, 1455, 1280 cm
-1
; 
1
H NMR (CDCl3)  3.40 (dd, 2H, H-
5’AB), 3.96 (dd, J=6.6, 3.8Hz, 1H, H-3’), 4.40-4.55 (m, 5H, H-2’, H-4’, OH, and CH of Bn), 
4.60 (d, J=12.0Hz, 1H, CH of Bn), 4.64 (d, J=12.6Hz, 1H, CH of Bn), 5.94 (bs, 1H, H-2), 
6.14 (dd, J=10.4, 1.1Hz, 1H, H-4), 6.81 (dd, J=10.4, 1.0Hz, 1H, H-3), 7.40-7.80 (m, 15H, 
3xPh); 
13
C NMR (CDCl3)  69.8 (t), 72.7 (t), 73.0 (t), 73.5 (t), 76.7 (d), 77.6 (d), 84.0 (d), 
88.6 (d), 102.6 (s), 127.0 (d), 127.6 (d), 127.8 (d), 127.9 (d), 128.1 (d), 128.2 (d), 128.3 
(d), 137.3 (s), 137.7 (s), 137.8 (s), 149.1 (d), 188.9 (s).  
Anal. calcd. for C30H30O7 on a diastereomeric mixture of 6b and 6’b: C, 71.70; H, 6.02. 
Found: C, 71.54; H, 5.90. 
Synthesis of  spiroketals 6c and 6’c: A 0.02M solution of  2c in 25mL di CH2Cl2 
anidro was photooxygenated as reported for furan 2a. When the photooxygenation 
reaction was complete (ca. 90 min), 2 equiv. of Et2S was added to the crude solution at 
-60°C. After 2h the crude solution was kept at -25°C overnight. Then, the solvent and 
the Et2S excess were removed under reduced pressure, and the silica gel 
chromatography (n-hexane/ethyl acetate 3/:7 v/v) afforded spiroketals 6c and 6’c in 
mixture (ca 2:1) . Yiels 25 %.  
Mixture of 5c and 6c in ca. 1:2 molar ratio:
1
H NMR(CDCl3) (selected signals) for 5c:  
2.74 (d, J=8.2 Hz, 1H, OH), 3.62 (m, 2H, H-5’AB), 4.18 (d, J=4.4Hz, 1H, H-2’), 4.22 (m, 1H, 
H-3’), 4.43-4.74 (m, 7H, CH2 H-4’ and CH2 of Bn), 6.08 (d, J= 8.2Hz, 1H, H-2), 6.76 (bs, 1 
H, H-3), 7.21-7.35 (m, 15H, 3xPh), 9.70 (s, 1H, CHO); for 6c 3.20 (d, J=7.4 Hz, 1H, OH), 
3.62 (m, 2H, H-5’AB), 4.02 (d, J=4.4Hz, 1H, H-2’), 4.20 (m, 1H, H-3’), 4.43-4.74 (m, 7H, H-
4’ and CH2 of Bn), 5.77 (d, J=7.4Hz, 1H, H-2), 6.80 (bs, 1H, H-3), 7.21-7.35 (m, 15H, 3x 
Ph), 9.70 (s, 1H, CHO).
13
C NMR(CDCl3) (selected signals)  70.2 (t), 70.3 (t), 78.6 (d), 81.3 
  
 
(d), 82.0 (d), 82.3 (d), 99.5 (d), 99.7 (d), 133.4 (s), 133.5 (s), 133.6 (s), 133.8 (s), 138.2 
(d), 138.4 (d), 188.2 (d), 188.3 (d).Anal. calcd. for C30H30O7 on a diastereomeric mixture 
of 5c and 6c: C, 71.70; H, 6.02. Found: C, 71.51; H, 5.85. 
 
Synthesis of spiroketal 7a: A mixture of spiroketals 6a and 6’a (0.5 mmol (311 mg))  
in molar ratio  1:1 ca, in 1.4mL di DMSO anhydrous. Then, acetic anhydride (0.8mL) was 
added and the resulting solution was stirred at r.t. under argon atmosphere. After ca 12 
h the reaction was quenched by adding H2O (ca. 10mL). The organic layer was extracted 
with CHCl3, washed with H2O (5x10 mL), dried on Na2SO4 and filtered. Then, the solvent 
was removed under reduced pressure and the residue was chromatographed on silica 
gel (n-hexane/ethyl acetate 7:3 v/v) affording spiroketal 7a in 74 % yield. 
O
BnO
BnO
BnO
BnO
7a
O
O
O
1'2'
3'
4'
5'
6'
1
2 3
45
 
7a:oil; 
1
H NMR (CDCl3)  = 3.64 (dd, J=11.3, 1.8Hz, 1H, H-6’A), 3.77 (dd, J= 11.3Hz, 3.9, 1 
H, H-6’B), 3.82 (t, J=9.4 Hz, 1H, H-4’), 4.08 (d, J= 9.7 Hz, 1H, H-2’), 4.20 (bt, J= 9.4 Hz, 2H, 
H-3’ e H-5’), 4.48 (d, J= 12.6 Hz, 1H, CH del Bn), 4.51 (d, J=11.5 Hz, 1H, CH del Bn), 4.58 
(d, J=12.6 Hz, 1H, CH del Bn), 4.61 (d, J=10.0Hz, 1H, CH del Bn), 4.84-4.90 (m, 4H, 2x CH2 
del Bn), 6.70 (d, J= 10.3Hz, 1H, H-4), 6.83 (d, J= 10.3Hz, 1H, H-3), 7.14-7.34 (m, 20H, 4x 
Ph); 
13
C NMR (CDCl3)  = 67.9 (t), 73.3 (t), 74.7 (d), 75.0 (t), 75.2 (t), 75.8 (t), 77.0 (d), 
79.8 (d), 82.1 (d), 101.7 (s), 127.5 (d), 127.6 (d), 127.7 (d), 128.3 (d), 135.0 (d), 136.9 (d), 
137.4 (s), 137.9 (s), 138.2 (s), 159.2 (s), 187.5 (s). 
 
EXPERIMENTAL-PART 2B 
Synthesis of 2-(2’,3’,4’,6’-tetra-O-benzyl-β-D-glucopyranosyl)furan (-
3a): To a solution of 616 mg (1mmol) of 2a in 10 mL of dry acetonitrile, cooled to -
40°C, was added 320 µL (2 equiv.) of triethylsilane and successively, 140 µL (1 equiv.) of 
BF3 • Et2O. The solution was stirred at -40°C for 1h, then a saturated aqueous solution of 
  
 
K2CO3 was added (10mL), and the mixture was kept under stirring for 10 min. The 
organic layer was extracted with ether (3x30 mL), washed with brine, dried over 
anhydrous Na2SO4 and filtered. Then the solvent was removed under reduced pressure 
and the residue was chromatographed on silica gel (n-hexane/ether 7:3 v/v) affording 
the β-C-glycoside -3a as white solid in 64% yield which was recognized by comparison 
with literature data (Czernecki et al.1989). 
 
Synthesis of 2-(2’,3’,5’-tri-O-benzyl-β-D-ribofuranosyl)furan (-3b): To a 
solution of 243 mg (0.5mmol) of 2b in 5.2mL of acetonitrile, cooled to -40°C, were 
added 240 µL (3 equiv.) of triethylsilane and 70 µL (1 equiv.) of BF3 • Et2O. The solution 
was stirred at -40 °C for 4 h and then the temperature was allowed to rise to r.t. while 
the mixture was further stirred overnight. Then, a saturated aqueous solution of K2CO3 
was added (10 mL), and the mixture was kept under stirring for 10min. The organic 
layer was extracted with ether (3x30 mL), washed with brine, dried over anhydrous 
Na2SO4 and filtered. The solvent was removed under reduced pressure and the residue 
was chromatographed on flash silica gel (n-hexane/ether 1:1v/v) affording the 
nucleoside -3c with 35 % yield (Macdonald et al.1988). 
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-3b: oil; 
1
H NMR (CDCl3); = 3.61 (m, 2H, H-5’A and H-5’B), 4.05 (t, J= 4.9 Hz, 1H, H-3’), 
4.18 (dd, J= 6.5, 4.9 Hz, 1H, H-2’), 4.30 (m, 1H, H-4’), 4.50-4.66 (m, 6H, CH2 of Bn), 5.04 
(d, J= 6.5Hz, 1H, H-1’), 6.34 (bs, 2H, H-3 and H-4), 7.23-7.33 (m, 15H, 3xPh), 7.34 (bs, 1 
H, H-5); 
13
C NMR;  = 70.3 (t), 72.1 (2 x t), 73.4 (t), 76.5 (d), 77.7 (d), 79.9 (d), 81.5 (d), 
108.9 (d), 110.3 (d), 127.5 (d), 127.6 (d), 127.7 (d), 127.8 (d), 128.0 (d), 128.3 (d), 137.7 
(s), 138.0 (s), 138.2 (s), 142.5 (d), 152.2 (s). 
 
  
 
Synthesis of 3-(2’,3’,5’-tri-O-benzyl-β-D-ribofuranosyl)furan (-3c): To a 
solution of 243 mg (0.5 mmol) of 2c in 5.2 mL of acetonitrile, cooled to -40 °C, was 
added 240 µL (3 equiv.) of triethylsilane and 70 µL (1 equiv.) of BF3 • Et2O. The solution 
was stirred at -40°C for 4h and then the temperature was allowed to rise to r.t. while the 
mixture was further stirred overnight. Then, a saturated aqueous solution of K2CO3 was 
added (10mL), and the mixture was kept under stirring for 10 min. The organic layer was 
extracted with ether (3x30mL), washed with brine, dried over anhydrous Na2SO4 and 
filtered. Then the solvent was removed under reduced pressure and the residue was 
chromatographed on flash silica gel (n-hexane/ether 1:1 v/v) affording the nucleoside -
3c with 30 % yield. 
1'2'3'
4'
5'
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BnO O
 
-3c:mp: 49–51 °C (hexane); 
1
H NMR:  = 3.56 (d, J= 10.4, 4.4 Hz, 1 H, H-5’A), 3.59 (d, J= 
10.4, 4.4Hz, 1H, H-5’B), 3.84 (dd, J= 6.6, 4.9 Hz, 1H, H-2’), 3.99 (dd, J= 4.9, 3.8 Hz, 1H, H-
3’), 4.28 (m, 1H, H-4’), 4.48-4.62 (m, 6H, CH2 of Bn), 4.97 (d, J=6.6 Hz, 1H, H-1’), 6.31 (bs, 
1H, H-4), 7.22-7.33 (m, 15H, 3xPh), 7.35 (bs, 1H, H-5), 7.40 (s, 1H, H-2); 
13
C NMR: = 
70.4 (t), 71.9 (t), 72.2 (t), 73.4 (t), 75.7 (d), 77.5 (d), 81.6 (d), 82.2 (d), 108.5 (d), 124.4 
(s), 127.6 (d), 127.7 (d), 127.8 (d), 128.0 (d), 128.3 (d), 137.7 (s), 137.9 (s), 138.1 (s), 
140.2 (d), 143.2 (d). 
 
One-pot synthesis of 3-(2’,3’,5’-tri-O-benzyl-β-D-
ribofuranosyl)pyridazine (-10b): A 0.02 M solution of -3b (0.5 mmol) in dry 
CH2Cl2 was photooxygenated as reported in the general procedure. The progress of 
each reaction was checked by periodically monitoring (TLC) the disappearance of -3b. 
When the photooxygenation reaction was complete (ca. 90 min), 2 equiv. of Et2S was 
added to the crude solution at -40°C. After 2h the crude solution was kept at room 
temperature overnight. Then, the solvent and the Et2S excess were removed under 
  
 
reduced pressure, and 2mL of hydrazine solution (2M in THF) were added at the 
residue. The resulting mixture was stirred at r.t. under nitrogen for 12h. Then, the 
solvent was removed under reduce pressure, and the silica gel chromatography (n-
hexane/ethyl acetate 1:1 v/v) afforded the pyridazine C-nucleoside -10c with 66 % 
yield from the starting glycosyl furan. 
O
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-10b: oil; 
1
H NMR (CDCl3); δ= 3.66 (dd, J= 10.4, 3.3 Hz, 1H, H-5’A), 3.88 (dd, J= 10.4, 2.5 
Hz, 1H, H-5’B), 3.97 (dd, J= 7.7, 4.9 Hz, 1H, H-3’), 4.31 (dd, J=4.9, 2.7 Hz, 1H, H-2’), 4.36 
(d, J=12.0 Hz, 1H, CH of Bn), 4.44 (m, 1H, H-4’), 4.50 (d, J=11.5 Hz, 1H, CH of Bn), 4.56(d, 
J= 12.0 Hz, 1H, CH of Bn), 4.57 (d, J= 11.5 Hz, 1H, CHof Bn), 4.74 (d, J= 12.0 Hz, 1H, CH of 
Bn), 4.86 (d, J= 12.0 Hz, 1H, CH of Bn), 5.48(d, J= 2.7 Hz, 1H, H-1’) 7.20 (dd, J= 8.8, 4.9 
Hz, 1H, H-5), 7.22-7.40 (m, 15H, 3xPh), 7.80 (dd, J=8.8, 1.6 Hz, 1H, H-4), 9.03 (dd, J= 4.9, 
1.6 Hz, 1H, H-6); 
13
C NMR; δ= 69.1 (t), 71.7 (t), 72.1 (t), 76.3 (d), 80.9 (d), 81.5 (d), 83.3 
(d), 124.9 (d), 126.6 (d), 127.7 (d), 127.8 (d), 128.2 (d), 128.3 (d), 137.7 (s), 138.0 (s), 
150.4 (d), 162.8 (s). 
One-pot synthesis of 4-(2’,3’,5’-tri-O-benzyl-β-D-
ribofuranosyl)pyridazine (-10c): A 0.02 M solution of -3c (0.5 mmol) in dry 
CH2Cl2 was photooxygenated as reported in the general procedure. The progress of 
each reaction was checked by periodically monitoring (TLC) the disappearance of -3c. 
When the photooxygenation reaction was complete (ca. 90 min), 2 equiv. of Et2S was 
added to the crude solution at -40°C. After 2h the crude solution was kept at room 
temperature overnight. Then, the solvent and the Et2S excess were removed under 
reduced pressure, and 2mL of hydrazine solution (2M in THF) were added at the 
residue. The resulting mixture was stirred at r.t. under nitrogen for 12h. Then, the 
solvent was removed under reduce pressure, and the silica gel chromatography (n-
hexane/ethyl acetate 1:1 v/v) afforded the pyridazine C-nucleoside -10c with 70% 
  
 
yield from the starting glycosyl furan. 
 
-10c: oil; 
1
H NMR (CDCl3); δ= 3.57 (dd, J= 10.4, 3.3 Hz, 1H, H-5’A), 3.65 (dd, J=10.4, 3.8 
Hz, 1H, H-5’B), 3.77 (dd, J=7.7, 4.9 Hz, 1H, H-2’), 4.02 (dd, J= 4.9, 2.7 Hz, 1H, H-3’), 4.38 
(m, 2H, H-4’ and CH of Bn), 4.51 (d, J= 12.0 Hz, 1H, CH of Bn), 4.56 (d, J= 12.0 Hz, 1H, CH 
of Bn), 4.57(d, J= 12.0 Hz, 1H, CH of Bn), 4.60 (s, 2H, CH2 of Bn), 4.98 (d, J= 7.7 Hz, 1H, H-
1’), 7.17-7.35 (m, 15H, 3xPh), 7.47 (bd, J=5.5 Hz 1H, H-5), 9.00 (d, J=5.5 Hz, 1H, H-6), 
9.16 (bs, 1H, H-3); 
13
C NMR; δ=70.1 (t), 72.7 (t), 73.6 (t), 78.6 (d), 82.7 (d), 83.4 (d), 
123.3 (d), 127.7 (d), 127.9 (d), 128.0 (d), 128.1 (d), 128.5 (d), 136.9 (s), 137.4 (s), 137.6 
(s), 140.3 (s), 149.7 (d), 151.0 (d). 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
CHAPTER 3. SYNTHESIS OF ARYL  
TRISUBSTITUTED FURANS AND APPLICATIONS IN 
THE FIELD OF LIGNANS 
 
 
3. INTRODUCTION 
Due to their numerous preparation methods and  the great synthetic versatility, furans 
have been used in the preparation of a high number of natural and synthetic 
compounds. In this part of the thesis applications of polysubstituted furans in the field 
of lignans have been realized.  
Lignans are among the main products of the secondary metabolism of the vascular 
plants. Basic structure consists of two phenylpropanoidic (C6-C3) units linked in 
different patterns. In plants, lignans show up as glicosides strongly connected to fiber 
constituents, and are taken in diets as inactive products. Afterwards, they are 
converted into phytoestrogens by removal of sugar residue by -galactosidase of 
intestinal bacteria. Active forms of lignans are (-)-enterolactone and (-)-enterodiol 
(FIGURE 3.1). 
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FIGURE 3.1 (-)-ENTEROLACTONE AND (-)-ENTERODIOL 
Probably lignans  play a key role in the defense mechanisms of the plant; so interest for 
a possible use in agriculture as environmentally friendly substances for defenses has 
revived. Lignans possess antimicrobial properties, antifungal, antiviral (Lacret et al. 
2012) antioxidant (Belmares et al. 1979; Figgitt et al.1989; Medarde et al. 1995), 
insecticidal (Oliveto 1972; Osawa et al. 1985;  Xue et al. 1992). In recent years these 
compounds have receved particular attention in pharmacological field for their effects 
on human health. Indeed they represent a source of phytoestrogens in diets for people 
who do not consume soy food. There are epidemiological and experimental data, 
which show a correlation between the uptaking phytoestrogens and a relative risk 
reduction of a cardiovascular disease, hypercholesterolemia (Adlercreutz and Mazur 
1997) menopause, osteoporosis and cancer, in particular cancer to mamelian and 
  
prostate. Many plants containing lignans have been used for centuries as medicinal 
plants and remedies for various aliments. One of the most diffuse lignans, interesting 
for cytostatic activity, is matairesinol (Figure 3.2) whose antitumoral properties against 
breast and colon cancers are well known (Thompson et al. 2006). 
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FIGURE 3.2 MATAIRESINOL 
Lignans derive from the oxidative dimerization of two phenylpropanoid (C6-C3) units, 
The phenylpropanoids units reveal different degree of oxidation and substitution, thus 
lignans show an enormous structural diversity, and numerous new compounds with 
structures correlated to lignans are continuously found. 
Lignans derive by the shikimic acid pathway (FIGURE 3.3) which also produces the 
aromatic aminoacids: phenylalanine and tyrosine (Jensen 1986). 
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FIGURA 3.3 SHIKIMIC ACID 
Lignans can be classified in classical lignans, which have the units linked in (8-8’) 
positions, and neolignans whose coupling patterns differ from such a ’ linkage 
(Saleem et al. 2005).The units can also be linked by an oxygen atom, as in the subclass 
of oxyneolignan (FIGURE 3.4).   
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FIGURE 3.4 TYPE OF LIGNANS 
The aromatic ring, which is formed starting from the shikimate pathway, may contain 
substituents such as hydroxyl and methoxyl groups in the 3,4,5 positions (FIGURE 3.5). 
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FIGURE 3.5 SUBSTITUENTS ON THE AROMATIC RING OF LIGNANS 
Despite the lignans are present in roots, leaves, seeds, rhizomes and fruits of more 
than seventy families of plants, such sources are not sufficient to "produce" a quantity 
commercially interesting. Isolation of lignans is very hard-working and of extremely low 
yields. The interest for these substances in the pharmaceutical and agricultural field, 
has given substantial impetus to research, aimed at optimizing the production of these 
substances on a larger scale, also through the development of new synthetic 
methodologies, industrially applicable with low production costs. 
Generally enzymatic and radical reactions have been employed, involving the coupling 
of phenoxy radicals (Iqbal et al. 1994). A synthetic method for the preparation of 
lignans (eg. dihydrodyisoeugenol and pinoresinol), starting from C6-C3 units has been  
based on photooxygenation reactions (Della Greca et al. 2008). As an alternative, the 
  
research group have recently recognized the possibility to synthetize lignan-like 
compounds starting from two units C3-C6 already linked in position β-β’ (FIGURE 3.6). 
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FIGURE 3.6 UNITS C3-C6 LINKED IN -'  
In particular, diarylfuranyl structures of  type A-C have been recognized as useful 
precursors of highly functionalized lignan-like compounds (FIGURE 3.7). 
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FIGURE 3.7 EXAMPLES OF DIARYLFURANIC STRUCTURES 
The introduction of furan systems in the scaffold of lignans appeared advantageous not 
only for the easy preparation of these heterocycles but especially for their high 
synthetic versatility. As evidenced above, furans are easily converted into reduced 
forms as dihydro and tetrahydrofurans or in oxidized forms such as furanones, 
structural units often present in natural lignans, or as versatile enediones (Keay et al. 
2005), that in turn  can lead to hetero and carbocyclic systems of great interest.The 
research group has developed a synthetic method for  furans with lignan-like structure 
of the type B (FIGURE 3A.2). The procedure employs an innovative Friedel-Crafts (FC) 
acylation starting from opportunely substituted 2-aryl-4-furoic acids (Comegna et al, 
2012). The novelty was the use  of trifluoromethylsulfonic anhydride (Tf2O) as promoter 
with reduction of steps and without the use of acid catalysts. An inconvenient was the 
formation of both regioisomers 3- and 4-aroylfurans, although appropriate reaction 
conditions allowed to obtain the planned appropriate lignan-like 4-aroyl-2-aryl furans 
as the main products (SCHEME 3.1). In the last year, great attention has been focused to 
the Friedel-Crafts reactions in order to avoid the use of  the required stoichiometric 
metal salts/acids in unfavorable conditions and increase the regioselectivity (kawamura 
  
et al. 2006; Firouzabadi et al. 2004). Tf2O is one of the most studied and applied 
catalyst; it is commercially available and known for its utility for the conversion of an 
OH group into an OTf leaving group.  
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SCHEME 3.1LIGNAN-LIKE FURANS 
 
In order to bring the arylaroylfuran structure to analogues present in nature, that 
possess the saturated non-oxidated chain, several attempts were made to reduce the 
carbonyl functions with unsatisfying results (SCHEME 3.2) (Comegna et al. 2012). 
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SCHEME 3.2. HYDROGENATION  OF CARBONYL FUNCTION 
 
Unsuccessful were some attempts to use the classical reactions of aromatic 
electrophilic substitution starting from halides in the presence of a Lewis acid (SCHEME 
3.3). 
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SCHEME 3.3. REACTION OF AROMATIC ELECTROPHILIC SUBSTITUTION 
Starting from these results, we decided to explore the possibility to synthetize furans of 
type 3 by Friedel-Crafts reaction of furanyl alcohol in the presence of Tf2O (SCHEME 3.4).  
  
 
SCHEME 3.4 FRIEDEL-CRAFTS ALKYLATION  
 
We were encouraged by literature data that reported successful FC alkylation of benzyl 
alcohols (Khodaei et al. 2012) in the presence of this reagent. The starting furan for 
furanyl alcohol was recognized a diester derivative as 1, easily prepared (Fan et al. 
2005). 
 
 
3A. SYNTHESIS OF DIARYL FURANS WITH LIGNAN BACKBONE BY 
NOVEL FRIEDEL-CRAFTS ALKYLATION 
RESULTS AND DISCUSSION: 
The following research plan was developed: 
 preparation of furan diester 1 
 reduction of furan 1 to obtain the furanyl alcohol 2  
 Friedel-Crafts alkylation (SCHEME 3A.1) 
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SCHEME 3A.1 RESEARCH DESIGN 
  
 
Synthesis of furans 1 
Furans 1a-c were prepared according to literature procedure (Fan et al. 2005) that 
involves the use of dimethyl acetylendicarboxylate (DMAD) and α-bromo aryl ketones 
in the presence of 1,4-diazabycyclo[2.2.2]octane (DABCO) and anhydrous K2CO3 (SCHEME 
3A.2). 
CO2Me
CO2Me
DABCO (20% mol)
K2CO3
CH2Cl2, t.a.
R
O
Br+
O
CO2MeMeO2C
R
1a-c  (yields>80%)
a) R = C6H5; b) R = 4-OMeC6H4 ; c) R = 4-BrC6H4  
SCHEME 3A.2  SYNTHESIS OF FURAN 1a-c 
To verify the role of the aromatic substiuent at 2-posistion, dimethyl furan-3,4-
dicarboxylate 1d was also prepared starting from commercially available furan-3,4-
dicarboxylic acid by methylation in the presence of diazomethane in diethyl ether and 
methanol at rt (SCHEME 3A.3). At the end of reaction, chromatography gave derivate 1d 
in 90 %  yield. 
O
MeO2C CO2Me
1d (yield>90%)
CH2N2 (Et2O)
MeOH, r.t.
O
HO2C CO2H
 
SCHEME 3A.3 SYNTHESIS OF FURAN 1d 
 
Synthesis of  furanyl alcohols 2 
 
4-(Hydroxymethyl)furans 2a, 2c, and 2d were prepared by NaBH4 reduction of the 
corresponding dimethyl furan-3,4-dicarboxylates 1a, 1c and 1d. The reaction was  
carried out in the mixed solvent system t-BuOH/MeOH (Soai et al. 1984) The resulting 
mixture was refluxed and stopped at ca. 50% conversion (ca. 2h) to avoid a high amount 
of the corresponding dialcohols (SCHEME 3A.4). 
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SCHEME 3A.4 FURANYL ALCOHOLS 2 PREPARATION 
The reaction was quenched with H2O and the residue extracted with CH2Cl2. The usual 
work up gave a residue that was purified by preparative silica gel TLC using as eluent 
hexane/AcOEt.  It is interesting to note the regiochemistry of the rroute that reduces 
only the ester function in 3 position, probably due to steric reasons. The dialcohol 2' 
was obtained in small amount after longer reaction time. Attempts to prepare furanyl 
alcohol 2b using this procedure failed. An alternative procedure was used (Longobardo 
et al. 2013) that requires a carboxylic function (SCHEME 3A.5). So, the dimethyl ester 1b 
was selectively hydrolyzed to 4-(methoxycarbonyl)-5-(4-methoxyphenyl)furan-3-
carboxylic acid 1b’ (Lin et al. 2001)  
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1eq, MeOH, t. a.
1b'  
SCHEMA 3A.5 HYDROLYSIS OF FURAN 1b 
Furoic acid 1b’ was firstly converted to a mixed anhydride using ClCOOMe in the 
presence of N-methylmorpholine (NMM) and then reduced with NaBH4 in H2O (SCHEME 
3A.6) (Longobardo et al. 2013).  
SCHEME 3A.6 SYNTHESIS OF FURANYL ALCOHOL 2b 
 
  
Friedel-Crafts alkylation reactions 
Initially, the reaction of methyl 4-(hydroxymethyl)-2-phenylfuran-3-carboxylate (2a) in 
the presence of Tf2O was examined with anisole under different conditions (SCHEME 
3A.7). 
Entry      Condition          T(°C)   time (t)    Yielda        4a/5a
O
MeO2C CH2OH
Ph
2a
Tf2O (2.5 equiv)
CH2Cl2 dry
OMe
(5 equiv)
O
MeO2C CH2
Ph
OMe
O
MeO2C CH2
Ph
4a 5a
+
MeO
1        Tf2O                 -20°C       20             61        68:32
2        Tf2O                  r.t              4             30         83:17
3    Tf2O/2,6-lutidine   -20°C       20            62         68:32
                a Chromatographic yield  
SCHEME 3A.7 ALKYLATION REACTIONS OF 2a IN DIFFERENT CONDITIONS 
The FC alkylation occurs in all cases regioselectively in favor of the para-isomer. The 
reaction in the presence of only Tf2O occurs with appreciable yield, mainly at low 
temperature. The products 4a and 5a were formed with a ratio of about 2:1 at -20°C in 
20h and  5:1 at rt in 4h. In an attempt to improve the yield, considering that triflic acid 
(TfOH) is generated, the reaction was also performed in the presence of a non-
nucleophilic base, 2,6-lutidine. No effect in total yield nor in the regioisomeric ratio was 
observed. Previously, these conditions were found particularly useful in Tf2O-mediated 
acylations (Della Greca et al. 2013; Grundl et al. 2006; Harmata and Jones 1996). 
 In the literature Khodaei and Nazari (2012) described a Friedel-Craft alkylation starting 
from variously substituted benzyl alcohols on different aromatic compounds in the 
presence of Tf2O in combination of triphenylphosphineoxide as activating agent. The 
activation mechanism is described in SCHEME 3A.8. 
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SCHEME 3A.8 ACTIVATION MECHANISM REACTION 
We therefore decided to apply the reaction of 2a with anisole under the Khodaei 
procedure. The reaction was carried out at rt for 1h and at 0°C for 5 h. As shown in 
SCHEME 3A.9, also in this case,the isomers 4a and 5a were obtained in similar amounts 
but  the reaction time was significantly reduced. 
.
O
MeO2C CH2OH
Ph
2a
Tf2O/Ph3PO
OMe
(5 equiv)
O
MeO2C CH2
Ph
OMe
O
MeO2C CH2
Ph
4a 5a
+
MeO
Condition           T(°C)                        time(h)           Yield(%)      4a/5a
Tf2O/Ph3PO       r.t                              1                         61            60: 40
 Tf2O/Ph3PO       0                                5                         56           71:29  
SCHEME 3A.9 Tf2O/Ph3PO -PROMOTED FRIEDEL-CRAFTS ALKYLATION OF ALCOHOL 2a 
Encoraged by these results, we applied the reaction of anisole under the Khodaei–
Nazari procedure (furanyl alcohol, anisole and TPPD in 1:1:1.2 molar ratio, rt) to 
differently substituted furanyl alcohols 2b-2d and to dialcohol 2a’ (SCHEME 3A.10). 
Entry R1 R2 Yield %
a 4/ 5
1
2
3
4
5
2a
2b
2c
2d
2a'
C6H5
4-MeO-C6H4
4-Br-C6H4
H
C6H5
CO2Me
CO2Me
CO2Me
CO2Me
CO2H
61
58
55
41
0
aYield of isolated product after •¡preparative TLC
 4a/5a  60:40
 4b/5b  62:38
 4c/5c    61:39
 4d/5d   58:42
O
CH2R2
R1O
CH2OHR2
R1
Tf2O/Ph3PO 
CH2Cl2
2 4
OMe
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SCHEME 3A.10 ALKYLATION REACTION OF 2b-d AND 2'a WITH ANISOLE 
  
As shown in SCHEME 3A.10, the reaction occurs except for dialcohol 2’a. Moreover, the 
aryl substitution of furan ring appears not essential. In these cases, the ratio of 
regioisomers is still in favor of 4 due to the lower steric crowding of the corresponding 
diaryl furan products. 
To extend the scope for preparation of lignan-like compounds, starting from furans 2a 
and 2b the alkylation was performed using other aromatic substrates with lignan-
typical aryl substitution (Pan et al. 2009; Saleem et al. 2005), such as phenol and 1,2-
dimethoxybenzene (SCHEME 3A.11). 
 
SCHEME 3A.11 Tf2O/Ph3PO-PROMOTED FRIEDEL-CRAFTS ALKYLATION OF ARENES  WITH FURANYL ALCOHOLS 2 
 
A different position selectivity was observed in the alkylation of 1,2-dimethoxybenzene 
probably since the electronic effect of the donating substituent is also of importance 
(Carey and Sundberg 2007). The alkylation worked, although with low yield, even with 
phenol that gives no reaction starting from benzyl alcohols (Khodaei and Nazari 2012). 
High regioselectivity at the ortho position of the phenol is observed, as also reported in 
similar cases (Li and Qu 2012). 
 
Antibiotic activity of some derivatives 
In order to evaluate anti-biofilm properties against Staphylococcus aureus and 
Staphylococcus epidermidis, some compounds (5g, 4i, 5h and 5i, (FIGURE 3A.1)) will be 
tested for the ability to inhibit  bacterial biofilms formation. These tests were 
performed in collaboration with Prof. Buommino (Department of Environmental, 
  
Biological and Pharmaceutical Sciences and Technologies-Second University of 
Naples)(Prof. Buommino). 
 
FIGURE 3A.1 LIGNAN.LIKE FURANS TESTED 
 
Bacteria that generate biofilms (Worthington et al. 2012) are highly organized surface-
associated communities encased within a self produced extracellular matrix, capable of 
growing in connection with different biological or inert surfaces such as artificial joints, 
contact lens or catheters. They cause many health problems, as endocarditis, otitis 
media, periodontitis, prostatitis,chronic wounds and urinary tract infections. The 
presence of a matrix prevents the access of antibiotics to the bacterial cells. 
Staphylococcus aureus and Staphylococcus epidermidis are two biofilm-forming species, 
principal aetiological agents of nosocomial infections. In order to evaluate antibiotic 
properties against Staphylococcus aureus and Staphylococcus epidermidis, some 
compounds were tested for the ability to inhibit bacterial growth. In FIGURE 3A.2 and 
FIGURE 3A.3 bacterial growth is shown in terms of turbidity (NTU Nephelometric 
Turbidity Units), measured at 630 nm. Lower the turbidity more active is  the product. 
As demonstrated in FIGURE 3A.2 a clear decrease of the growth of Staphylococcus 
epidermidis was observed in the presence of compounds 4i and 5i. Compound 5i 
displayed the best effects at 32 µg/ml. 
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FIGURE 3A.2 THE S. EPIDERMIDIS GROWTH IN THE PRESENCE OF COMPOUNDS 5g, 4i, 5h AND 5i. THE RESULTS ARE 
EXPRESSED AS TURBIDITY (NTU) COMPARED TO RESPECTIVE CONTROL WELLS 
 
 
As shown in FIGURE  3A.3  compounds 5g and 5h ( at 128 µg/ml and 64 µg/ml ), 5i (at 128 
µg/ml ,64 µg/ml and 32 µg/ml)  were able to decrease the growth of  S. aureus. 
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FIGURE 3A.3 EFFECTS OF COMPOUNDS 5g, 4i, 5h and 5i ON S. AEREUS GROWTH. THE RESULTS ARE EXPRESSED AS 
TURBIDITY (NTU) COMPARED TO RESPECTIVEC ONTROL WELLS 
 
 
 
  
3B. DYE-SENSITIZED PHOTOOXYGENATION OF ARYL 
TRISUBSTITUTED FURANS AND APPLICATIONS IN THE FIELD OF 
LIGNANS 
In this part attention was paid to the reactivity of trisubstituted arylfurans toward  
singlet oxygen. During a study directed to the synthesis of compounds with  lignan-like 
structure starting from , '-dicarbomethoxy arylfurans some peculiar results were 
highlighted in"classical" reactions of the related endoperoxides obtained by dye-
sensitized photooxygenation (DellaGreca et al. 2013). This prompted to investigate on 
the reactivity of these furan derivatives by examining mainly substituent effects and to 
exploit the synthetic potential. In particular, we decided to verify the role of the 
aromatic group and that of the ester group in two general applications of the 
photooxygenation of furans, reduction for the preparation of enediones and base 
treatment for acrylic acids and 4-hydroxybutenolides. As reported above, the nature 
and position of substituents have a prominent role in the behavior of furan 
endoperoxides (Iesce et al. 2005; Gollnick et al. 1985; Graziano et al. 1980), and furans 
as 1 (FIGURE 3B.1) were not previously examined. 
O
R2 R3
R1 H
R1            Aryl or Alkyl
R2 =R3    Ester, ketone or alkylic group
1
 
FIGURE  3B.1. TRISUBSTITUED FURANS 1  
Furans examined  were substituted in position by an aryl or an alkyl group while in 
positions they have an ester or ketone or alkyl group (FIGURE 3B.1).  
  
RESULTS AND DISCUSSION: 
Furans 1 examined are reported in FIGURE 3B.2   
 
Furan R2R1 R3
1a                C6H5                           CO2Me                   CO2Me          
1b                4-MeO-C6H4         CO2Me                       CO2Me    
1c                4-Br-C6H4                CO2Me                   CO2Me    
1l                 C6H11                         CO2Me                   CO2Me    
1m               C6H5                    CO2Me                   4-MeOC6H4-CO  
1n                C6H5                    4-MeOC6H4-CO     CO2Me    
1o                C6H5                    CO2Me                   CH2OCOMe
1p                C6H5                    CO2Me                   4-MeOC6H4-CH2
O
R2 R3
R1 H
1
 
FIGURE 3B.2  FURANS 1 SYNTHETIZED 
 
Synthesis of  other furans of type 1 
Furan 1l was  prepared according to the literature procedure (Fan et al. 2005) adopted 
for furans 1a-c (page 70), by DABCO-catalyzed reaction of dimethyl 
acetylendicarboxylate (DMAD) and 2-bromo-1-cyclohexylethanone, the latter prepared 
by bromination of cyclohexylethanone (SCHEME 3B.1).   
CO2Me
CO2Me
DABCO (20% mol)
K2CO3 CH2Cl2, t.a.
O
Br+
O
CO2MeMeO2C
1l (80%)  
SCHEME 3B.1 SYNTHESIS OF FURAN 1l 
After work-up and chromatography 1l was obtained in satisfactory yields (80%) and 
fully characterized.  
Furans 1m and 1n were obtained by a reported procedure (Comegna et al. 2012), by 
selective hydrolysis of derivate 1a to the corresponding acid followed by Tf2O-mediated 
Friedel-Crafts acylation (SCHEME 3B.2). 
  
1n (10%)
KOH (1eq)
MeOH, rt O
Ph
CO2Me
O
MeO
+
1a
O
MeO2C CO2Me
Ph
O
MeO2C
Ph
O
OMe
O
MeO2C COOH
Ph
1m (83%)
   Tf2O (2.5eq),
anisole, 12h, -30°C
 
SCHEME 3B. 2 PREPARATION OF FURANS 1m AND 1n 
Furan 1o was obtained by acetylation of alchool 2a previously synthetized by NaBH4 
reduction  (SCHEME 3B.3). 
2a 1o
O
MeOOC CH2OH
O
MeOOC CH2OCOMe
piridine, rt
Ac2O
 
SCHEME 3B. 3 PREPARATION OF 1o 
Photooxygenation reactions 
The photooxygenation reaction was performed under conventional conditions: low 
temperature (-20°C), dichoromethane as solvent (usually 10
-2
 M) and methylene blue as 
sensitizer, sunlight lamp, dry oxygen flux. The reaction was checked by TLC 
(disappearance of furan) and 
1
H NMR. It was complete within 2-3 h. Endoperoxides 
were quantitatively formed and they were spectroscopically characterized at r.t. 
(characteristic CH signal in the  range 6.80-6.20 typical of an acetalic proton in an 
unsaturated bicyclic structure (Gollnick et al. 1985;Graziano et al. 1987) In furan system 
the  resonance  of H-5 is at  7.90-7.96). (SCHEME 3B.4) 
 
 
O
R3R2
R1
1
h, O2, MB
CH2Cl2, -20 °C O O
OR1
R3R2
6 (95%)
 
SCHEME 3B.4 DYE-SENSITIZED PHOTOOXYGENATION OF FURANS 1 
 
  
Endoperoxides 6a-c and 6l-n exhibited a quite thermal stability while 6o,p quickly 
converted in a mixture of unidentified products. The peculiar thermal stability of 
endoperoxides 6a-c and 6l-n can be explained considering that furan endoperoxide 
stability is significantly increased by the presence of electron-withdrawing groups on 
the double bond (Graziano et al. 1982).  It was suggested that the thermal stability 
should be due to the delocalization of  electrons in the furan endoperoxide structure 
by electron-withdrawing groups, and this should ensure that the reactivity of this 
system lay between that of mono-ozonides of cyclobutadiene derivatives and that of 
the most stable ozonides of cyclobutene derivatives (Graziano et al. 1982). Reduction 
and base treatment were however performed starting from all furans 1. Indeed, the 
reactivity of furan endoperoxides, even unstable, can be controlled and opportunely 
addressed working at low temperature (Iesce et al. 2012). 
 
Et2S reduction 
Photooxygenation followed by treatment in situ with Et2S, led to the expected cis-
aldehydes 7 in the series a-c,m,n,p (SCHEME 3B.5). 
 
Furan R2R1 R3
1. 1O2
2. Et2S
for l,o
complex mixtures
R2 R3
CHO
O
R1
7a-c,m,n, p  (90%)
O
R3R2
R1
1
1a                C6H5                                     CO2Me                        CO2Me 
1b               4-MeO-C6H4                   CO2Me                              CO2Me    
1c                4-Br-C6H4                          CO2Me                      CO2Me    
1l                 C6H11                                   CO2Me                      CO2Me    
1m               C6H5                          CO2Me                       4-MeOC6H4-CO  
1n                C6H5                          4-MeOC6H4-CO         CO2Me    
1o                C6H5                          CO2Me                       CH2OCOMe
1p                C6H5                          CO2Me                       4-MeOC6H4-CH2  
SCHEME 3B.5 ONE-POT METHODOLOGY FOR ALDEHYDES 7 
These compounds were spectroscopically characterized. The reduction is almost 
quantitative except for 1n (>40%) and 1p(>20%). Despite the low temperature attempts 
to obtain aldehydes 7l and 7o failed since the reactions afforded complex mixtures. 
  
Evidently, reduction competes with thermal conversion and this could be due to 
different thermal stability of endoperoxides and mildness of the reduction reagent 
(Et2S) (Gollnick et al. 1985). Derivatives 7a,c,m,n (kept at room temperature in CDCl3) 
converted partly into products to which we tentatively assigned structures 8a,c,m,n 
(SCHEME 3B.6).  
Aldehyde       R1                                R2                            R3
R2 R3
O
R1
7 a,c,m,n
O
H
O
O
R1
R2
R3
8a,c,m,n
H
a            C6H5                        CO2Me                      CO2Me
c             4-Br-C6H4                    CO2Me                      CO2Me
m           C6H5                         CO2Me                     4-MeOC6H4CO   
n             C6H5                        4-MeOC6H4CO        CO2Me  
SCHEME 3B.6 REARRANGEMENTS OF OXOALDEHYDES 7a,c,m,n AND SUGGESTED FORMATION PATHWAYS OF 5,6-
DIOXABICYCLOHEXENES 8a,c,m,n 
These compounds were not isolated by chromatography and were identified on the 
basis of NMR data of the mixtures by subtracting NMR signals of aldehydes 7a-c,n,p. In 
particular, in the 
1
H-NMR of the mixture of 7c and 8c (1:3 molar ratio) dimethyl 1-(4-
bromophenyl)-5,6-dioxabicyclo[2.1.1]hex-2-ene-2,3-dicarboxylate(8c) exhibited two 
doublets at   7.44 and 7.38, a singlet at   6.13 and two singlet of methoxy signals at  
3.83 and 3.66. In the HSQC spectrum these protons were correlated to the carbons at  
131.1, 128.0, 99.6, 53.4 and 52.4, respectively. Furthermore, 
13
CNMR analysis showed 
the presence of the quaternary acetalic carbon at  107.6. This carbon showed 
correlations, in the HMBC spectrum, with protons at  6.13 and 7.37 assigned to the 
acetalic and aromatic protons, respectively. The acetalic proton, in the HMBC 
experiment, gave heterocorrelation with the quaternary carbons at  143.4 and 135.5. 
On contrast, when the reduction mixture from 1b was kept in CDCl3 and/or 
chromatographed by TLC, lactone 10b was isolated (SCHEME 3B.7). 
  
MeO2C CO2Me
O
7b
O
H
O
MeO2C
O
H
9b
O
MeO2C
10b
O
CO2Me
H
CO2Me
MeO
MeOMeO
 
SCHEME 3B.7 REARRANGEMENT OF OXOALDEHYDE 7b AND SUGGESTED FORMATION PATHWAY FOR LACTONE 10b 
A rare example of 5,6-dioxabicyclo[2.1.1]hexane such as 8 has been reported and was 
obtained by hydroxyhydroperoxy-2,5-dihydrofurans by protic acids (Graziano and Carli 
1982). In our cases, formation of 8 could be due to the concomitant presence of the 
aldehydic group and -oxoaryl function that promotes the easy attack of one carbonyl 
oxygen to the electrophilic carbon followed by ring closure to 8 (SCHEME 3B.6). 
Alternatively, from 7b silica gel or slightly acid traces promote formation of lactone 10b 
and this likely occurs via undetected labile epoxide 9b (SCHEME 3B.7). This trend appears 
consistent with the electronic effects of the 4-methoxyaryl substituent. Intermediates 
as 9 have been sometime evidenced by NMR in the oxidation of furans (Adam et al. 
1991) as well as rearrangements of epoxides to carbonyl compounds are reported and 
are particularly favoured in condensed or ester derivatives (Adam et al. 1991b; Baylon 
and Hanna 1995).  
Control experiments conducted starting from 1b, showed that as expected, owing to 
electron deficiency these furans , were not oxidized by peracids. In addition, oxidants as 
bromine or NBS did not react cleanly and afforded mixtures of products (SCHEME 3B.8).  
 
  
O
COOMeMeOOC
1b
Br2
NBS,THF-H2O
MeO
Mixture of  products
no reaction
no reaction
MeOOC COOMe
O O
HMeO
7b  (20%)
m-CPBA
CH2Cl2, 0C, 1h
0°C,1h
1.1O2
2. Et2S
7 b( 85%)
MeOOC COOMe
O O
HMeO
 
SCHEME 3B.8 COMPARISON OF VARIOUS OXIDATION METHODS 
On contrast, the photooxygenation followed by reduction is clean and occurs 
quantitatively as evidenced by the proton spectrum of the crude reaction mixture from 
1b (FIGURE 3B.3). Hence, this two-step one-pot reaction represents a useful alternative 
to oxidize electron-poor furans 1a-c,n,p respect to classical methods (Merino et al. 
2007; Piancatelli et al. 1994; Kobayashi et al. 1998; Gingerich and Jennings 1984).  
 
 
 
 
 
FIGURE 3B.3 
1
H NMR SPECTRUM OF THE CRUDE REDUCTION MIXTURE OF  1b 
Base treatment 
The base treatment was carried out by adding 1.2 equiv of diethylamine to the 
photooxygenation mixture at low temperature of furans 1a-c,l-o and the resulting 
mixture was kept at rt for about 30 min. The base attack to the acid bridged hydrogen 
(Kernan and Faulkner 1988; Graziano and Iesce 1985) led to an open oxidized product 
MeOOC COOMe
CHO
O
7b
MeO
  
instead of the expected lactone for all series (SCHEME 3B.9). As an example, 
13
C-NMR 
spectrum of the mixture from 1a, in addition to the two signals of ester carbons, 
showed the presence of two new downfield signals at  192.5 and 166.9 due to the 
aromatic ketone and COOH group, respectively. All acids 11 were obtained in cis-
configuration.  
 
1. 1O2, CH2Cl2, -20 °C
2. Et2NH, -20 °C       r.t.
R2 R3
COOH
O
R1
11 (95%)
O
R3R2
R1
1  
 
SCHEME 3B.9  ONE-POT PROCEDURE FOR ACIDS 11 
 
Similar results were obtained with tertiary amines, as Et3N or DABCO. Anyhow, the best 
choice for obtaining acids 11 without further purification turned out to use Et2NH that 
can be removed under reduced pressure in the presence of phosphorous anhydride. 
Having aldehydes 7 in the hands, we tried to oxidize them to acids 11. All attempts 
using classical or novel (Lim et al. 2007; Malik and Chakraborty 2010)  methods failed 
leading to the starting aldehydes or tarry mixtures of products (SCHEME 3B.10).  
 
MeOOC
COOMe
O
H
O
7a
no reaction
Cr2O3
fragmentations
PCC
no reaction
Bi2O3-oxidation
t-BuOOH
 
SCHEME 3B.10 OXIDATIONS OF ALDEHYDE 7a 
 
Instead, the one-pot procedure reported in  SCHEME 3B.9  is clean and quantitative as 
evidenced by the proton spectrum of the crude reaction mixture of 1a (FIGURE 3B.3). 
 
  
 
 
MeOOC COOMe
COOH
O
11a  
 
 
 
 
 
FIGURE 3B.4 
1
H-NMR SPECTRUM OF THE CRUDE BASE TREATMENT MIXTURE OF  1a 
 
MB-sensityzed photooxygenation of furans 1 in acetone 
Conversion of furans 1a-c,l,m into the corresponding -hydroxybutenolides 12 was 
readily accomplished in excellent yields when the photooxygenation was carried out in 
acetone at -20°C and the resulting endoperoxides slowly warmed to r.t. (SCHEME 3B.11).  
 
Furan R2R1 R3
1O2, Acetone
-20 °C       r.t.
O O
R3R2
R1
HOO
R3R2
R1
1
12 (90%)
1a                  C6H5                                          CO2Me                   CO2Me          
1b                4-MeO-C6H4                          CO2Me                      CO2Me    
1c                  4-Br-C6H4                                CO2Me                 CO2Me    
1l                 C6H11                                        CO2Me                 CO2Me    
1m                C6H5                                  CO2Me               4-MeOC6H4-CO  
SCHEME 3B.11 ONE-POT PROCEDURE FOR -HYDROXYBUTENOLIDES 12 
Under the same conditions furans 1o,p gave complex thermal-conversion mixtures. 
Also in these cases the reaction was particularly clean as evidenced by the proton 
spectrum of the crude mixture of 1c (FIGURE 3B.5 ). 
  
 
O O
COOMeMeOOC
HO
12c
Br
 
 
 
           FIGURE 3B.5 1H-NMR SPECTRUM OF THE CRUDE OXYGENATION MIXTURE OF  1c IN ACETONE 
Control experiments showed that when butenolides 12 were treated with Et2NH they 
immediately converted to acids 11 confirming that these conditions favour the acid 
open-form (SCHEME 3B.12). 
R2 R3
COOH
O
R1
11
O O
R3R2
R1
HO
12
Et2NH
 
SCHEME 3B.12 CONVERSION OF BUTENOLIDES 12 INTO ACIDS 11 
 
 
 
 
  
3C.  CONCLUSION 
In this part of PhD thesis a novel synthetic method has been developed for the  access 
to diaryl furans of type 4 and 5 with a lignan backbone by a variant  of the Friedel-Crafts 
reaction. 
 
O
CH2OHMeO2C
R1
+
R2
R3
Tf2O/Ph3PO
CH2Cl2, r.t.
O
CH2MeO2C
R1
R3
R2
+
O
CH2MeO2C
R1
R3R2
R1 = C6H5, 4-OMeC6H4, 4-BrC6H4, H
R2= OMe, OH  
   
R3= H, OMe
4                                              5
 
SCHEME 3C.1 Tf2O/Ph3PO PROMOTED FRIEDEL-CRAFTS ALKYLATION 
The results have highlighted that Tf2O is a promoting agent not only in Friedel-Crafts 
acylation reactions (Comegna et al. 2012), but also in Friedel-Crafts alkylations. To our 
knowledge Tf2O-mediated alkylation of furans was not reported prevously. The reaction 
uses furanyl alcohols as starting furans and a combination of Tf2O and  Ph3PO. Under 
these conditions the reaction time was significantly reduced and temperature from 0°C 
to r. t. could be used. The alkylation method occurred at room temperature in a short 
time, with a reduction of step and without  acid catalysts. The presence of furan system 
highlights manifold elaborations of the heterocyclic ring to a variety of product types 
(Keay et al. 2005; Keay et al. 2008). From a biological point of view, preliminary data 
obtained by Researchers of the Second University of Naples evidenced an antibiotic 
activity especially for  compound 5i (FIGURE 3C.1) which could be a good candidate as a 
possible antibiotic. 
  
 
FIGURE 3C.1 COMPOUND 5I 
In addition, studies directed to examine the reactivity of this furan-type and other 
trisubstituted aryl furans, previously not examined, toward singlet oxygen have  led to 
results particularly interesting and provide more knowledge on the reactivity and 
synthetic potential of furans. Despite the electrophilicity of singlet oxygen, the high 
propensity of furan system to add this species overcomes even the negative effects of 
the electron-withdrawing groups of furans 1. Substituent effects have evidenced that in 
the presence of two of these groups and an -aryl substituent the post-oxidative 
reactions appear particularly clean and afford useful C-4 synthons in excellent yields. All 
the reactions are one-pot (SCHEME 3C.2) and, due to the cyclic structure of the 
endoperoxide precursor, occur stereoselectively.  
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SCHEME 3C.2 APPLICATIONS OF DYE-SENSITIZED PHOTOOXYGENATION OD TRISUBSTITUTED ARYL FURANS  
 
The procedure to aldehydes  7 remains the most useful to obtain enediones from these 
electron-poor furans if compared with oxidations with peracids or bromine or NBS 
which do not occur or give not cleanly mixtures(Piancatelli et al. 1994; Kobayashi et al. 
  
1998; Gingerich et al. 1984).  Particularly interesting is the high-yield general route for 
versatile (DellaGreca et al. 2013) acids 11 since attempts to oxidize aldehydes 7 failed 
using various methods (Lim et al. 2007; Malik et al. 2010). Controlled reaction 
conditions allow to address the transformation to the corresponding cyclic forms 12. 
During this investigation novel highly functionalized lignan-like compounds have been 
obtained starting from a single trisubstituted aryl furan as reported for 1ain FIGURE 3C.2.  
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FIGURE 3C.2 FUNCTIONALIZED LIGNAN-LIKE COMPOUNDS FROM ARYL FURAN 1a 
 
 
 
 
 
 
  
3D.  EXPERIMENTAL SECTION 
LIST OF ABBREVIATIONS USED: 
DABCO = 1,4-diazabicycle[2.2.2]octane 
DMAD = dimethylacetilendicarboxylate 
EE = diethyl ether 
 EP = petroleum ether  
AcOEt = ethyl acetate  
DCM = dichlorometane 
MeOCOCl = methylchloroformiate 
Tf2O = anhydride trifluorometansolfonic 
r.t. = room temperature 
THF = tetrahydrofuran 
NMM = n-methylmorpholine 
 
Materials and methods: All reagents and solvents were obtained from 
commercial suppliers and used without further purification. 2-
Aryldicarbomethoxyfurans (Fan et al. 2005) were synthesized according to the 
literature; dimethyl furan-3,4-dicarboxylate was commercially available. 
1
H NMR (400 
MHz or 500 MHz) and 
13
C NMR (100 MHz or 126 MHz) spectra were recorded on a 
Bruker DRX-400 or INOVA 500 spectrometers at r.t. The carbon multiplicity was 
evidenced by DEPT experiments. The proton couplings were evidenced by 
1
H–
1
H COSY 
experiments. The heteronuclear chemical shift correlations were determined by HMQC 
and HMBC pulse sequences. IR spectra were recorded on a Jasco FT/IR-
430spectrometer. Electronic impact mass spectra (EI-MS) were recorded on a GC-MS 
QP5050A (Shimadzu) equipped with a 70 eV EI detector.Thin layer chromatography 
(TLC) was performed on aluminum plates precoated with Merck Silica Gel 60 F254 as 
the adsorbent (0.25, 0.50, 1.0 and 2.0 mm). Flash column chromatography was 
conducted on Kieselgel 60, 230-400 mesh (Merck), at medium pressure. Column 
chromatography was conducted on Silica Gel 0.06-0.20 mm mesh (Merck Kieselgel). 
  
Experimental-Part 3A  
 
Synthesis of dicarboxymethoxyfurans 1a-c,l: 2.70 mmol of 2-
bromoacetophenone and 0.27 mmol of DABCO  in 10 ml di DCM. The mixure kept to 
stirring at room temperature for 30 min, than 4.06 mmol of  K2CO3 and  1.35 mmol of 
DMAD were added. The reaction was conducted over nigth (~15 h) in stirring.The 
mixture reaction was extracted with H2O and CH2Cl2.The organic layer was collected, 
dried over anhydrous Na2SO4, filtered and concentrated to give a residue that was 
purified by flash column chromatography under dry nitrogen pressure. The eluent 
depended on product: 1a with EtOAc/EP 10% (85% yield), 1b with EtOAc/Hex 20% (66% 
yield), 1c with EtOAc/PE 10% (70% yield) and 1e EtOAc/EP 10% (75% yield) 
 
2-FENIL-3,4-DICARBOXYMETHYL FURAN (1a) 
 
O
MeO2C CO2Me
1a  
 
1a:
1
H NMR (500MHz)  δ : 7.97 (s, 1H, H-5), 7.70 (m, 3H, H-3
’
- 4
’
- 5
’
), 7.40 (d, J= 7.4 
Hz, 2H, H-2
’
- 6
’
), 3.91 (s, 3H, α-OMe), 3.86 (s, 3H, β-OMe); 
13
C NMR (125MHz) δ: 
165.0 (C-β), 162.3 (C-α), 154.1 (C-2), 146.3 (C-1
’
-5
’
), 128.7 (C-3’-5’), 126.4 (C-2’-6’), 
119.8 (C-4), 113.5 (C-3), 52.7 (β-OMe), 52.0 (α-OMe). 
DIMETHYL-2(4-METOXYPHENYL)FURAN-3,4-DICARBOXYLATE (1b) 
 
O
MeO2C CO2Me
1b
MeO
 
 
  
1b:
1
H NMR (500MHz)  δ: 7.91 (s, 1H, H-5), 7.67 (d, J = 9.0 , 2H, H-2
’
and 6
’
), 6.94 (d, J 
=9.0, 2H, H-3’ and 5’), 3.89 (s, 3H, α-OMe), 3.85 (s, 3H, 4’-OMe), 3.84 (s, 3H, β-OMe) 
; 
13
C NMR (125MHz) δ: 165.1 (C-β), 162.6  (C-α), 160.8 (C-4’), 154.9 (C-2), 145.9 (C-
5), 114.3 (C-3’-5’),128.4 (C-2’-6’), 121.6 (C-1), 119.9 (C-4), 112.3 (C-3), 52.7 (β-OMe), 
52.1 (α-OMe), 55.5 (4’-OMe). 
DIMETHYL-2-(4-BROMOPHENYL)FURAN-3,4-DICARBOXYLATE (1c) 
O
MeO2C CO2Me
1c
Br
 
1c:
1
H NMR (500MHz)  δ : 7.96 (s, 1H, H-5), 7.58 (d, J = 8.8 , 2H, H-2
’
and 6
’
), 7.54 (d, J 
= 8.8, 2H, H-3’ and 5’), 3.90 (s, 3H, α-OMe), 3.86 (s, 3H, β-OMe); 
13
C NMR (125MHz) 
δ: 164.5 (C-β), 162.0 (C-α), 153.1 (C-4’),152.0 (C-2), 146.4 (C-5131.9 (C-2’-6’), 127.9 
(C-1), ), 127.0 (C-3’-5’),  123.7 (C-4), 119.9 (C-3), 52.7 (β-OMe), 52.0 (α-OMe). 
 
DIMETHYL 2-CYCLOHEXYLFURAN-3,4-DICARBOXYLATE (1l) 
 
O
MeO2C CO2Me
1l  
1l:oil;IR (CH2Cl2) 1735, 1713 cm-1; 
1
H NMR (500MHz, CDCl3) : 7.74 (s, 1H, H-5), 3.87 (s, 
3H, OCH3), 3.83 (s, 3H, OCH3), 2.84 (m, 1H, H-1’), 2.20-1.20 (m, 10H, H-2’-H-5’); 
13
C NMR 
(125MHz) : 165.9, 163.8, 162.8, 145.2, 118.4, 111.2, 51.9 (x2), 36.8, 30.8 (x2), 26.0 
(x2), 25.7; EI-MS: m/z = 266.3 [M]+. 
 
Synthesis of furans 1m,n : Furans 1mand 1n were prepared according to literature 
procedures (Comegna et al. 2012). 
 
  
METHYL 4-(4-METHOXYBENZOYL)-2-PHENYLFURAN-3-CARBOXYLATE (1m) 
O
MeO2C
O
OCH3
1m
 
 
1m:oil;IR (CH2Cl2): 3021, 2942, 1716, 1612, 1604, 1240, 1035 cm
-1
; 
1
H NMR (500 MHz, 
CDCl3) δ 7.91 (d, J = 8.9 Hz, 2H, Ar-H), 7.88 (dd, J = 8.4, 1.6 Hz, 2H, Ar-H), 7.74 (s, 1H, H-
Furan), 7.46-7.44 (m, 3H, Ar-H), 6.97 (d, J = 8.9 Hz, 2H, Ar-H), 3.89 (s, 3H, -OCH3), 3.65 
(s, 3H, -COOCH3); 
13
C NMR (126MHz, CDCl3) δ 187.4, 164.1, 163.7, 156.2, 143.9, 131.5, 
130.9, 129.7, 128.5, 127.8, 120.9, 120.6, 113.9, 111.7, 55.5, 52.0; EI-MS m/z= 336.10 
[M]
+
. 
 
METHYL 4-(4-METHOXYBENZOYL)-5-PHENYLFURAN-3-CARBOXYLATE (1n) 
 
O
OCH3
OO
H3CO
1n  
 
1n: oil; IR (CH2Cl2): 3020, 1725, 1660, 1598, 1217, 1165 cm
-1
; 
1
H NMR (400MHz, CDCl3) 
δ 8.11 (s, 1H, H-Furan), 7.90 (d, J = 8.7 Hz, 2H, Ar-H), 7.55 (dd, J = 8.0, 1.7 Hz, 2H, Ar-H), 
7.31-7.27 (m, 3H, Ar-H), 6.91 (d, J = 8.7 Hz, 2H, Ar-H), 3.85 (s, 3H, -OCH3), 3.66 (s, 3H, -
OCH3); 
13
C NMR (100MHz, CDCl3) δ 190.9, 164.0, 162.4, 152.1, 146.5, 131.8, 130.5, 
128.9, 128.8, 125.7, 120.9, 119.6, 114.0, 55.5, 51.7; EI-MSm/z= 336.10 [M]
+
.  
 
Synthesis of methyl 4-(acetoxymethyl)-2-phenylfuran-3-carboxylate (1o): 
0.5mmol of alcohol 2a see below in presence of 0.75 ml of acetic anhydride and 0,5 ml 
of pyridine kept to stirring at room temperature over night. The residue  was purified 
by  column chromatography with  EtOAc/EP 20% .Derivate 1o was obtained with a yield 
of 90%. 
  
O
CH2OAcMeOOC
1o  
 
1o:IR (CH2Cl2) 1740, 1721 cm-1; 
1
H NMR (400MHz, CDCl3) 7.81 (m, 2H, Ar-H), 7.49 (s, 
1H, H-5), 7.42 (m, 3H, Ar-H), 5.23 (s, 2H, -CH2O-), 3.81 (s, 3H, OCH3), 2.12 (s, 3H, CH3); 
13
C NMR (126MHz, CDCl3) δ 170.6 (OCOCH3), 163.9 (COOCH3), 158.9 (C-2), 140.9 (C-5), 
129.7 (C-1’), 129.5 (C-4’), 128.6 (C2’ and C-6’), 128.1 (C-3’ and C-5’), 122.3 (C-3), 112.3 
(C-4), 58.0 (-CH2-), 51.5 (OCH3), 20.9 (COCH3); EI-MS: m/z = 274.3 [M]+. 
Furan 1p (≡ 4a) was prepared as above. 
 
Synthesis of furanyl alcohols 2a,a’,c,d: Methanol (4ml) was added over a 
period of 1h to a refluxing mixture of NaBH4 (175mg, 4.6mmol) and dimethyl 2-
phenylfuran-3,4-dicarboxylate (1.2 g, 4.6mmol) in t-BuOH (18ml). The resultant mixture 
was refluxed for 2h. The reaction was quenched by addition of H2O (12ml). Most of the 
organic solvents were evaporated on a rotary evaporator, and residue extracted with 
dichloromethane. The combined organic extracts were dried over anhydrous Na2SO4. 
After the evaporation of the solvent, the residue was chromatographed on silica gel  
column using EtOAc-hexane 10%  and gave: starting diester (37% yield), 2a (50% yield ) 
and diol 2a’ (13% yield). 
 
O
MeO2C CH2OH
2a  
METHYL 4-(HYDROXYMETHYL)-2-PHENYLFURAN-3-CARBOXYLATE (2a) :IR (CH2Cl2) 3655, 3065, 
2990, 1717, 1600, 1282. 
1
H NMR (500MHz, CDCl3): 7.71-7.69 (m, 2 H, H-2’ and H-6’); 
7.45 (s, 1 H, H-5); 7.44- 7.42 (m, 3 H, H-3’- H-5’); 4.63 (s, 2 H, -CH2O-); 3.81(s, 3 H, MeO). 
13
C NMR (126 MHz, CDCl3): 165.2 (COOMe); 159.3 (C-2); 139.8 (C-5); 130.0 (C-1’); 129.5 
  
(C-3’and C-5’); 128.8 (C-4’); 128.0 (C-2’) e C-6’); 127.3 (C-3); 112.5 (C-4); 55.9 (-CH2O-); 
51.8 (MeO). EI-MS: m/z = 232.07 [M]+. 
 
O
HOH2C CH2OH
2a'  
 
(2-PHENYLFURAN-3,4-DIYL)DIMETHANOL (2’a): IR (CH2Cl2) 3695, 3560, 3065, 2990, 1600, 
1282. 
1
H NMR (500MHz, CDCl3): 7.59 (m, 2 H, H-2’ and H-6’); 7.41 (t, 2 H, J=7.7, H-3’ 
and H-5’); 7.38 (s, 1H, H-5); 7.32 (dd, 1H, J= 10.8, 4.0, H-4’); 4.70 (s, 2H, -CH2O-); 4.56 (s, 
2H, -CH2O-). 
13
C NMR (126MHz, CDCl3): 153.1 (C-2); 139.3 (C-5); 130.5 (C-1’); 128.7 (C-3’ 
and C-5’); 128.1(C-4’); 126.7(C-2’ and C-6’); 126.5 (C-3); 119.5 (C-4); 55.3(CH2); 54.5 
(CH2). EI-MS: m/z = 204.08 [M]
+
. 
 
Furan 2c was prepared using the same procedure of 2a starting from dimethyl 2-(4-
bromophenyl)furan-3,4-dicarboxylate (676 mg, 2 mmol).Yield:43% 
 
 
O
MeOOC CH2OH
2cBr  
 
METHYL 2-(4-BROMOPHENYL)-4-(HYDROXYMETHYL)FURAN-3-CARBOXYLATE (2c): oil; IR (CH2Cl2): 
3617, 2947, 2918, 3040, 1694, 1476, 1129,912, 835. 
1
H NMR (400MHz, CDCl3): 7.58 (d, 
J=8.3,H-2’and H-6’; 7.55 (d, J=8.5, H-3’ and H-5’); 7.44 (s, H-5); 4.61 (s, CH2); 3.80 (s, 
Me). 
13
C NMR (101MHz, CDCl3):165.1 (COOMe); 157.0 (C-2); 140.0 (C-5); 131.2  (C-3’ 
and C-5’); 130.3 (C-2’ and C-6’); 128.8 (C-4’); 127.4 (C-3); 123.9 (C-1’); 112.8(C-4); 55.8 (-
CH2O-); 51.9 (COOMe). 
 
  
Furan 2d was prepared using the same procedure of 2a starting from dimethyl furan-
3,4-dicarboxylate (368 mg, 2 mmol), commercially available. Yield:40%  
 
O
MeOOC CH2OH
2d  
METIL 4-(HYDROXYMETHYL)FURAN-3-CARBOXYLATE (2d): IR (CH2Cl2): 1708, 1543, 1315, 1143, 
1107, 1019. 
1
H NMR (400MHz, CDCl3): 7.97 (s, 1H, H-2); 7.39 (s, 1H, H-5); 4.61 (s, 2H, -
CH2O-); 3.86 (s, 3H, MeO). 
13
C NMR (101MHz, CDCl3): 164.9 (COOMe); 149.3 (C-2), 
141.1 (C-5), 125.2 (C-3), 117.8 (C-4), 55.3 (-CH2O-), 51.9 (COOMe);EI-MS: m/z = 156.07 
[M]+. 
 
Synthesis of furanyl alcohol 2b: To a solution of 4-(methoxycarbonyl)-5-(4-
methoxyphenyl)furan-3-carboxylic acid, (735 mg, 2.7mmol) and NMM (391 l, 3.5 
mmol) in THF (8.8 ml)  methyl chloroformate (270 l, 3.5 mmol) was added dropwise at 
0°C under stirring.  After 2h, the solution was filtered, and the salt was washed with 
THF (3x2.5ml). A suspension of NaBH4 (147 mg, 3.89 mmol) in H2O (1ml) was then 
added dropwise to the filtrate in an ice bath under stirring. After 2h the temperature 
was allowed to increase to r. t. After 20 min, the solvent was evaporated under reduced 
pressure and the residue dissolved in EtOAc (15ml). The solution was washed with 
brine until neutral. The organic layer was separated, dried over Na2SO4, filtered and 
concentrated to give the crude alcohol that was purified by gel chromatography using 
EtOAc-n-hexane 30%. Yield 40% 
 
O
MeOOC CH2OH
2bMeO  
 
  
METHYL 4-(HYDROXYMETHYL)-2-(4-METHOXYPHENYL)FURAN-3-CARBOXYLATE (2b): IR (CH2Cl2): 
3700, 3060, 3040, 1717, 1600, 1282. 
1
H NMR (500MHz, CDCl3): 7.67 (br d, 2 H, J = 8.8, 
H-2’ and H-6’); 7.41 (s, 1 H, H-5); 6.95 (d, 2 H,  J = 8.9, H-3’ and H-5’); 4.62 (s, 2 H, -CH2O-
); 3.86 (s, 3 H, MeO); 3.81 (s, 3 H, MeO). 
13
C NMR (126MHz, CDCl3): 165.3 (COOMe); 
160.5 (C-4’); 159.5 (C-2); 139.3 (C-5); 130.3 (C-2’) and C-6’); 128.2 (C-3); 122.5 (C-1’); 
113.5 (C-3’ and C-5’); 111.5 (C-4); 55.9 (-CH2O-); 55.3 (MeO); 51.7 (COOMe). EI-MS: m/z 
= 262.28 [M]
+
. 
 
Friedel–Crafts alkylation experiments of furanyl alcohol 2a (Scheme 
3a.7): Pure 2a (58 mg, 0.25 mmol) was dissolved in 2ml of dry solvent (DCM) and then 
5 equiv of anisole was added. The mixture was cooled to -20 °C and Tf2O (2.5 equiv) 
added dropwise at this temperature. On completion of the reaction (controlled by TLC), 
the mixture was washed with saturated NaHCO3 solution and extracted twice with ethyl 
ether. The organic layer was collected, dried over anhydrous Na2SO4, filtered and 
concentrated to give a residue that was chromatographed on preparative silica gel TLC 
using DCM-n-hexane 10% as eluent.  
Pure 2a (58 mg, 0.25 mmol) was dissolved in 2ml of dry DCM and then 5equiv of anisole 
was added. The mixture was cooled to -20 °C and Tf2O (2.5 equiv) added dropwise at 
this temperature. Then 2,6-lutidine (2.5 equiv) was added at the same temperature. 
The resulting mixture was stirred under N2 atmosphere at -20° C for 20 h. Work up and 
purification were performed as reported above. 
General procedure for Tf2O-Ph3PO mediated Friedel-Crafts alkylation of 
furanyl alcohols 2: To a solution of Ph3PO (0.6 mmol) in dry DCM (1 ml), Tf2O (0.1 
ml, 0.6 mmol) was added at 0°C and the mixture was stirred for 15 min at room 
temperature. Then, arene (0.5 mmol) and furanyl alcohol (0.5 mmol in 1 ml of dry 
CH2Cl2) were added and the mixture was stirred. Upon completion of the reaction (1h), 
the organic solvent was evaporated and the residue was chromatographed by 
preparative TLC using EtOAc-n-hexane as eluent. 
  
Synthesis of methyl 4-(4-methoxybenzyl)-2-phenylfuran-3-carboxylate 
(4a) and methyl 4-(2-methoxybenzyl)-2-phenylfuran-3-carboxylate (5a): 
Prepared according GP using furanyl alcohol 2a (116 mg) and anisole (54 mg, 55 l). 
Purification was achieved by preparative TLC (n-hexane/AcOEt 9:1).  4a(37%) and5a 
(24%). 
O
MeO2C
4a
OMe
 
4a: IR (CH2Cl2): 1715, 1547, 1493, 1441,1213, 1086, 1030. 
1
H NMR (400MHz, CDCl3): 
7.76 (d, 2H, J = 7.9, H-2’ and H-6’); 7.46–7.36 (m, 3H, H-3’ and H-5’);  7.18 (d, 2H,  J = 
8.4, H-2” and H-6”); 7.04 (s, 1H, H-5); 6.86 (d, 2H, J=8.5, H-3” and H-5”); 3.93 (s, 2H, -
CH2-); 3.81 (s, 3 H, MeO); 3.75 (s, 3 H, MeO).
13
C NMR (101MHz, CDCl3): 164.8 (COOMe); 
158.2 (C-4”); 157.9 (C-2); 140.1 (C-5); 131.6 (C-1’); 130.1 (C-1”); 129.7 (C-2”and C-6”); 
129.0 (C-4’) 128.5 (C-3’and C-5’); 128.1 (C-2’ and C-6’); 122.3 (C-3); 113.7 (C-3” and C-
5”); 110.4 (C-4); 55.2 (MeO); 51.3 (COOMe); 30.3 (-CH2-). EI-MS: m/z = 322.12 [M]
+
.  
O
MeO2C
5a
MeO
 
 
5a: IR (CH2Cl2): 1715, 1547, 1493,1440, 1215, 1076. 
1
H NMR (400MHz, CDCl3): 7.77 (br 
d, 2H, J = 7.8, H-2’ and H-6’), 7.43-7.35 (m, 3 H, H-3’ and H-5’), 7.23 (t, 1H, J = 8.0, H-4”), 
7.17 (d, 1H, J = 7.5, H-6”), 7.00 (s, 1H, H-5), 6.90 (dandt, 3 H, J = 7.4, H-3” and H-5”), 
3.99 (s, 2H, -CH2-), 3.84 (s, 3H, MeO), 3.76 (s, 3H, MeO). 
13
C NMR (101MHz, CDCl3): 
165.8 (COOMe); 157.7 (C-2); 157.5 (C-2”); 140.2 (C-5); 130.8 (C-1’); 130.0 (C-6”); 129.0 
(C-4’); 128.7 (C-3); 128.2 (C-3’ and C-5’); 128.0 (C-2’ and C-6’); 127.5 (C-4”); 126.2 (C-
1”); 120.4 (C-5”); 110.3 (C-4 and C-3”); 55.3 (MeO), 51.2 (COOMe), 25.2 (-CH2-). EI-MS: 
m/z = 322.10 [M]
+
. 
  
 
Synthesis ofmethyl 4-(4-methoxybenzyl)-2-(4-methoxyphenyl)furan-3-
carboxylate (4b) and 4-(2-methoxybenzyl)-2-(4-methoxyphenyl)furan-3-
carboxylate (5b): Prepared according GP using furanyl alcohol 2b (131mg) and 
anisole (54mg, 55 l). Purification was achieved by preparative TLC (n-hexane/AcOEt 
9:1) and led to 4b (35%) and 5b (22%).   
O
MeO2C
4b
OMe
MeO
 
4b: IR (CH2Cl2): 1716, 1535, 1493, 1439, 1213, 1070. 
1
H NMR (400MHz, CDCl3: 7.76 (d, J 
= 8.6, H-2
’
and H-6’); 7.19 (d,J = 8.4, H-2’’and H-6’’); 7.01 (s, H-5); 6.97, 6.96 (d, J = 8.4, H-
3’ and H-5’); 6.87 (d, J=8.5, H-3’’ and H-5’’); 3.94 (s,CH2); 3.87 (s, Me); 3.82 (s, Me); 3.76 
(s, Me).
13
C NMR (101MHz, CDCl3): 164.8 (COOMe),160.3 (C-4’), 158.6 (C-4”), 158.0 (C-
1), 139.5 (C-5), 131.9 (C-1’), 129.9 (C-2’ and C-6’), 129.7 (C-2” and C-6”), 127.2 (C-3), 
122.9 (C-1”), 113.8 (C-3’ and C-5’), 113.5 (C-3”) and C-5”), 55.3 (MeO), 55.3 (MeO), 51.2 
(COOMe), 30.5 (-CH2-); EI-MS: m/z = 352.15 [M]
+
.  
O
MeO2C
5b
MeO
MeO
 
 
5b: IR (CH2Cl2): 1716, 1530, 1491, 1439, 1213, 1054, 1019. 
1
H NMR (400MHz, CDCl3): 
7.76 (d, 2 H, J=9.0, H-2’ and  H-6’); 7.24 (td, 1 H, J=7.8, 1.7, H-4”); 7.19 (br d, 1 H, J=7.9, 
H-6”); 6.98–6.93 (m, 4 H, H-5, H-3’, H-5’ and H-5”); 6.91 (d, 1 H, J = 7.9, H-3”); 4.00 (s, 
2H, -CH2-), 3.87 (s, 3H, MeO); 3.86 (s, 3H, MeO); 3.77 (s, 3H, MeO). 
13
C NMR (101MHz, 
CDCl3): 165.0 (COOMe); 160.2 (C-4’); 158.3 (C-2); 157.4 (C-2”); 139.7 (C-5); 130.1 (C-6”); 
129.9 (C-2’ and C-6’); 129.7 (C-1’); 128.3 (C-3); 127.5 (C-4”); 126.1 (C-1”); 120.5 (C-5”); 
  
113.8 (C-4); 113.5 (C-3’ and C-5’); 110.4 (C-3”); 55.4 (MeO); 55.3 (MeO); 51.2 (COOMe); 
25.4 (-CH2-). EI-MS: m/z = 352.09 [M]
+
. 
 
Synthesis of methyl 2-(4-bromophenyl)-4-(4-methoxybenzyl)furan-3-
carboxylate (4c) and methyl 2-(4-bromophenyl)-4-(2-
methoxybenzyl)furan-3-carboxylate (5c): Prepared according GP using furanyl 
alcohol 2c (155 mg) and anisole (54 mg, 55 l). Purification was achieved by preparative 
TLC (n-hexane/AcOEt 85:15) and led to 4c (33%) and 5c (21%).  
O
MeO2C
4c
OMe
Br
 
4c: IR (CH2Cl2): 1716, 1611, 1512, 1176, 1078. 
1
H NMR (400MHz, CDCl3): 7.66 (d, 2H, J = 
7.3, H-2’ and H-6’); 7.54 (d, 2H, J=7.3, H-3’and H-5’); 7.16 (d, 2 H, J=7.6, H-2” and H-6”); 
7.03 (s, 1H, H-5); 6.85 (d, 2H, J=7.3, H-3” and H-5”); 3.91 (s, 2H, -CH2-); 3.80 (s, 3H, 
MeO); 3.75 (s, 3H, MeO).
13
C NMR (101MHz, CDCl3): 164.5 (COOMe); 158.0 (C-4”); 157.0 
(C-1); 140.3 (C-5); 131.5 (C-1’); 131.2 (C-3’and C-5’); 129.8 (C-2”and C-6”); 129.6 (C-
2’and C-6’); 129.0 (C-1”); 127.5 (C-2); 123.4 (C-4’); 113.8 (C-4, C-3”and C-5”); 55.2 
(MeO); 51.4 (COOMe); 30.3 (-CH2-). EI-MS: m/z = 400.06 [M]
+
. 
O
MeO2C
5c
Br
MeO
 
5c:IR (CH2Cl2): 1716, 1605, 1522, 1175, 1080. 
1
H NMR (400MHz, CDCl3): 7.67 (d, 2H, J= 
7.1, H-3’and H-5’); 7.53 (d, 2H, J=7.1, H-2’and H-6’); 7.23 (m, 1H, H-4”); 7.16 (d, 1H, 
J=7.4, H-6”); 6.99 (s, 1H, H-5); 6.90 (br t, 2H, J=7.6, H-3”and H-5”); 3.97 (s, 2H, -CH2-); 
3.84 (s, 3H, MeO), 3.77 (s, 3H, OCH3). 
13
C NMR (101MHz, CDCl3): 164.7 (COOMe); 157.2 
(C-2”); 156.7 (C-1); 140.5 (C-5); 131.2 (C-3’and C-5’); 130.0 (C-6”); 129.9 (C-2’and C-6’); 
  
129.2 (C-1’); 127.9 (C-3); 127.6 (C-4”); 126.4 (C-1”); 123.3(C-4’); 120.5 (C-5”); 113.8 (C-
4); 110.3 (C-3”); 55.3 (MeO); 51.4 (COOMe); 25.3 (-CH2-). EI-MS: m/z =400.04 [M]
+
. 
 
Synthesis of methyl 4-(4-methoxybenzyl)furan-3-carboxylate (4d) and 
methyl 4-(2-methoxybenzyl)furan-3-carboxylate (5d): Prepared according 
GP using furanyl alcohol 2d (78mg) and anisole (54mg, 55 l). Purification was achieved 
by preparative TLC (n-hexane/AcOEt 9:1, two runs)  and led to 4d (29%) and 5d (17%). 
O
MeO2C
4d
OMe
 
4d: IR (CH2Cl2): 1722, 1600, 1588, 1494, 1091. 
1
H NMR (500MHz, CDCl3): 7.99 (d, 1H, 
J=1.7, H-2); 7.18 (d, 2H, J=8.6, H-2’ and H-6’); 7.03 (d, 1H, J=1.7, H-5); 6.86 (d, 2H, J=8.6, 
H-3’and H-5’); 3.95 (s, 2H, -CH2-); 3.82 (s, 3H, MeO), 3.81(s, 3H, MeO). 
13
C NMR (101 
MHz, CDCl3): 164.0 (COOMe); 158.0 (C-4’); 149.0 (C-2), 141.7 (C-5); 131.6 (C-1’); 129.6 
(C-2’and C-6’); 125.6 (C-3);118.0 (C-4); 113.7 (C-3’ andC-5’); 55.1 (MeO); 51.1 (COOMe); 
29.4 (-CH2-). EI-MS: m/z = 246.08 [M]
+
. 
O
MeO2C
5d
MeO
 
5d: IR (CH2Cl2): 1720, 1599, 1585, 1490, 1091. 
1
HNMR (500MHz, CDCl3): 7.98 (s, 1H, H-
2), 7.23 (t, 1H, J=7.8, H-4’); 7.19 (d, 1H, J=7.1, H-6’); 7.00 (s, 1H, H-5); 6.92-6.89 (dandt, 
2H, H-3’ and H-5’); 4.01 (s, 2H, -CH2-); 3.84 (MeO); 3.83 (MeO). 
13
CNMR (126MHz, 
CDCl3): 164.1 (COOMe); 157.3 (C-2’); 148.7 (C-2); 142.1 (C-5); 130.1 (C-6’); 128.3 (C-1’); 
127.6 (C-4’); 124.4 (C-3); 120.4 (C-5’); 118.2 (C-4); 110.4 (C-3’); 55.3 (MeO); 51.2 
(COOMe); 24.4 (-CH2-). EI-MS: m/z = 246.11 [M]
+
. 
  
Synthesis of methyl 4-(3,4-dimethoxybenzyl)-2-phenylfuran-3-
carboxylate (4e): Prepared according GP using furanyl alcohol 2a (116 mg) and 1,2-
dimethoxybenzene (69 mg). Preparative TLC (n-hexane/AcOEt  8:2) gave only isomer 
4e(53%). 
O
MeO2C
4e
OMe
OMe
 
4e: IR (CH2Cl2): 1715, 1514, 1214, 1139, 1028. 
1
HNMR (400MHz, CDCl3): 7.78 (dd, 2H, J = 
7.8, 1.4, H-2’and H-6’); 7.46-7.38 (m, 3H, H-3’ ̶ H-5’); 7.06 (s, 1H, H-5); 6.87-6.78 (m, H-
2”, H-5” and H-6”); 3.96 (s, 2H, -CH2-), 3.90 (s, 3H, MeO), 3.88 (s, 3H, MeO), 3.78 (s, 3H, 
OCH3). 
13
CNMR (101MHz, CDCl3): 164.7 (COOMe); 158.2 (C-1); 148.9 (C-3”); 147.5 (C-
4”); 140.1 (C-5); 132.2 (C-1’); 130.3 (C-1”); 129.2 (C-4’); 128.3 (C-3’and C-5’); 128.1 (C-2’ 
and C-6’); 127.3 (C-3); 120.7 (C-6”); 112.1 (C-2”); 111.4 (C-4); 111.2 (C-5”); 55.9 
(MeO);55.9 (MeO); 51.3 (COOMe); 30.9 (-CH2-). EI-MS: m/z = 352.08 [M]
+
. 
Synthesis of methyl 4-(3,4-dimethoxybenzyl)-2-(4-
methoxyphenyl)furan-3-carboxylate (4f) andmethyl 4-(2,3-
dimethoxybenzyl)-2-(4-methoxyphenyl)furan-3-carboxylate (5f): 
Prepared according GP using furanyl alcohol 2b (131 mg) and 1,2-dimethoxybenzene 
(69 mg). Purification was achieved by preparative TLC (n-hexane/AcOEt. 8:2) and led to 
4f (26%) and 5f (36%).  
O
MeO2C
4f
OMe
OMe
MeO
 
  
4f: IR (CH2Cl2): 1714, 1500, 1177, 1076, 1029. 
1
H NMR (400MHz, CDCl3): 7.76 (d, 2H, J = 
9.1, H-2’and H-6’); 7.01 (s, 1H, H-5); 6.96 (d, 2H, J=9.1, H-3’ and H-5’); 6.86-6.77 (m, 3H, 
H-2”, H-5”and H-6”); 3.95 (s, 2H, -CH2-); 3.89 (s, 3H, MeO); 3.88 (s, 3H, MeO), 3.87 (s, 
3H, MeO), 3.77 (s, MeO). 
13
C NMR (101MHz, CDCl3): 164.4 (COOMe); 160.3 (C-4’); 158.4 
(C-2); 148.8 (C-4”); 147.8 (C-3”); 139.5 (C-5); 132.2 (C-1’); 129.9 (C-2’and C-6’); 129.8 (C-
1”); 127.1 (C-3); 120.7 (C-6”); 113.4 (C-3’and C-5’); 112.1 (C-2”); 111.2 (C-5”); 111.1 (C-
4); 55.9 (MeO); 55.8 (MeO); 55.3 (MeO); 51.2 (COOMe); 31.0 (-CH2-). EI-MS: m/z = 
382.07 [M]
+
.  
O
MeO2C
5f
OMe
MeO
MeO
 
5f: IR (CH2Cl2): 1715, 1580, 1170, 1076, 1025. 
1
H NMR (400MHz, CDCl3): 7.76 (d, 2H, J = 
9.1, H-2’and H-6’); 7.03 (t, 1H, J=7.8, H-5”); 6.98–6.93 (s+d, 3H, H-5, H-3’and H-5’); 6.84 
(dd, 1H, J = 8.2, 1.5, H-6”); 6.81 (dd, 1H, J=7.7, 1.5, H-4”); 4.03 (s, 2H,-CH2-); 3.90 (s, 3H, 
MeO); 3.87 (s, 3H, MeO); 3.84 (s, 3H, MeO), 3.78 (s, 3H, MeO). 
13
C NMR (101MHz, 
CDCl3): 167.7 (COOMe); 160.4 (C-4’); 158.3 (C-2); 152.9 (C-2” and C-3”); 139.7 (C-3); 
133.8 (C-2); 130.1 (C-2’and C-6’); 123.7 (C-6”); 122.9 (C-1’); 122.2 (C-5”); 113.4 (C-3’and 
C-5’); 110.8 (C-4”); 60.6 (MeO); 55.7 (MeO); 55.2 (MeO); 51.3 (COOMe); 25.4 (-CH2-). EI-
MS: m/z = 382.10 [M]
+
. 
Synthesis of methyl 4-(4-hydroxybenzyl)-2-phenylfuran-3-carboxylate 
(4g) and methyl 4-(2-hydroxybenzyl)-2-phenylfuran-3-carboxylate (5g): 
Prepared according GP using furanyl alcohol 2a (116mg) and phenol (47mg). 
Preparative TLC (DCM/AcOEt 9:1) gave 4g (1%) and 5g (14%). 
O
MeO2C
4g
OH
 
  
4g: IR (CH2Cl2): 3200, 1718, 1589, 1492, 1324, 1085. 
1
H NMR (400MHz, CDCl3): 7.75 (dd, 
2H, J=8.0, 1.6, H-2’and H-6’); 7.45-7.35 (m, 3H, H-3’and H-5’); 7.12 (d, 1 H, J=8.5, H-
2”and H-6”); 7.03 (s, 1H, J=7.5, H-5); 6.78 (d, 2H, J= 8.5, H-3”and H-5”); 3.91 (s, 2H, -CH2-
), 3.74 (s, 3H, MeO). EI-MS: m/z = 308.07 [M]
+
. 
O
MeO2C
5g
HO
 
5g: IR (CH2Cl2): 3201, 1719, 1589, 1482, 1328, 1080. 
1
H NMR (400MHz, CDCl3): 7.66 (dd, 
2H, J = 6.6, 3.1, H-2’and H-6’); 7.44-7.38 (m, 3H, H-3’and H5’); 7.20 (d, 1H, J=7.6, H-6”); 
7.15 (t, 1H, J=7.5, H-5”); 6.92-6.86 (m, 2H, H-2”and H-3”); 6.84 (s, 1H, H-5); 3.98 (s, 2H, -
CH2-), 3.79 (s, 3H, MeO). 
13
C NMR (101MHz; CDCl3) δ 162.0 (COOMe); 154.4 (C-2); 150.0 
(C-2”); 136.6 (C-5); 126.5 (C-6”); 126.2 (C-1’); 125.3 (C-4’); 124.6 (C-2’and C-6’); 124.2 
(C-5”); 124.0 (C-3’ and C-5’); 122.1 (C-1”and C-4”); 121.8 (C-3); 116.7 (C-3”); 112.6 (C-4); 
47.8 (MeO); 20.9 (-CH2-). EI-MS: m/z = 308.11 [M]
+
. 
 
Synthesis of methyl 4-(4-hydroxybenzyl)-2-(4-methoxyphenyl)furan-3-
carboxylate (4h) and methyl 4-(2-hydroxybenzyl)-2-(4-
methoxyphenyl)furan-3-carboxylate (5h): Prepared according GP using furanyl 
alcohol 2b (116mg) and phenol (47mg). Preparative TLC (DCM/AcOEt 9:1) gave 4h (7%) 
and 5h (28%).  
O
MeO2C OH
MeO 4h  
 
4h: IR (CH2Cl2): 3200, 1719, 1578, 1492, 1325, 1083. 
1
H NMR (400 MHz, CDCl3): δ7.73 
(d, 2H, J=9.0 Hz, H-2’ and H-6’), 7.12 (d, 2H, J=8.4 Hz, H-2”and H-6”), 6.99 (s, 1H, H-5), 
6.93 (d, 2H, J=9.0 Hz, H-3’ and H-5’), 6.77 (d, 2H, J=8.5 Hz, H-3” and H-5”), 3.90 (s, -CH2-
), 3.85 (s, MeO), 3.73 (s, MeO). 
13
C NMR (101MHz; CDCl3): δ 164.7 (COOMe); 160.1 (C-
  
4’); 153.8 (C-2) and C-4”); 139.4 (C-5); 131.9 (C-1’); 129.8 (C-2’, C-6’, C-2”, and C-6”); 
127.1 (C-1”); 122.8 (C-3); 115.2 (C-3’) and C-5’); 113.4 (C-3” and C-5”); 112.0 (C-4); 55.2 
(MeO); 51.1 (MeO);  30.4 (-CH2-).EI-MS: m/z = 338.12 [M]
+
. 
 
O
MeO2C
5h
HO
MeO  
 
5h:IR (CH2Cl2): 3201, 1720, 1579, 1486, 1324, 1081. 
1
H NMR (400MHz, CDCl3):δ 7.63 (d, 
2H, J=9.0 Hz, H-2’ and H-6’), 7.21 (s, 1H, H-5), 7.19 (dd, 1H, J= 7.8, 1.5 Hz, H-6”), 7.14 
(m, 1H, H-4”), 6.93 (d, 2H, J=9.0 Hz, H-3’ and H-5’), 6.90 – 6.86 (m, 2H, H-3” and H-5”), 
3.98 (-CH2-), 3.85 (MeO), 3.79 (MeO). 
13
C NMR (101MHz; CDCl3) δ 165.9 (COOMe); 
160.3 (C-4’); 158.8 (C-2”); 153.9 (C-2); 139.9 (C-5); 130.4 (C-6”); 130.1 (C-2’ and C-6’); 
128.0 (C-4”); 126.1 (C-1’); 125.6 (C-1”); 120.6 (C-5”); 122.8 (C-3); 116.5 (C-3”); 113.4 (C-
3’ and C-5’); 111.3 (C-4); 55.2 (MeO); 51.6 (MeO); 24.9 (-CH2-). EI-MS: m/z = 338.11 
[M]
+
. 
Synthesis of methyl 2-(4-bromophenyl)-4-(4-hydroxybenzyl)furan-3-
carboxylate (4i)andmethyl 2-(4-bromophenyl)-4-(2-hydroxybenzyl)furan-3-
carboxylate (5i): Prepared according GP using furanyl alcohol 2c (116mg) and phenol 
(47mg). Preparative TLC (DCM/AcOEt 9:1) gave 4i (44%) and 5i (39%). 
O
MeO2C OH
Br 4i  
 
4i: IR(CH2Cl2): 3201, 1718, 1639, 1495, 1300, 1084. 
1
H NMR (400MHz, CDCl3): 7.66 (d, 2 
H, J =10.5 Hz, H-2’ and H-6’); 7.56 (d, 2H, J = 10.5 Hz, H-3’ and H5’); 7.13 (d, 2 H, J = 8.1 
Hz, H-2” and H-6”); 7.06 (s, 1 H, H-5); 6.80 (d, 2H, J = 8.1 Hz, H-3” and H-5”); 3.92 (s, 2 H, 
-CH2-), 3.75 (s, 3H, MeO). 
13
C NMR (101MHz; CDCl3) δ 164.2 (COOMe); 157.2 (C-4”); 
154.0 (C-2); 140.3 (C-5); 132.0 (C-1’); 131.7 (C-2’ and C-6’); 129.9 (C-3’ and C-5’); 129.8 
  
(C-2” and C-6”); 128.0 (C-1”); 127.5 (C-3 and C-4’); 113.7 (C-4, C-3” and C-5”); 51.3 
(MeO); 30.5 (-CH2-). EI-MS: m/z = 386.02 [M]
+
. 
O
MeO2C
5i
HO
Br  
 
5i: IR (CH2Cl2): 3202, 1719, 1639, 1497, 1290, 1084. 
1
H NMR (400MHz, CDCl3):7.59 (d, 2 
H, J = 6.6 Hz, H-2’ and H-6’); 7.57 (d, 2H, J = 6.6 Hz, H-3’ and H-5’); 7.25 (s, 1 H, H-5); 
7.21 (dd, 1H, J = 7.6, 1.1 Hz, H-6”); 7.15 (td, 1 H, J=7.7, 1.6 Hz,  H-4”); 6.95-6.85 (m, 2 H, 
H-3” and H-5”); 4.00 (s, 2H, -CH2-), 3.82 (s, 3H, MeO). 
13
C NMR (101MHz; CDCl3) δ 165.5 
(COOMe); 157.2 (C-2); 153.7 (C-2”); 140.8 (C-5); 131.3 (C-3’ and C-5’); 130.4 (C-6”); 
130.1 (C-2’ and C-6’); 129.1 (C-1’); 128.0 (C-4”); 126.1 (C-1”); 125.9 (C-3); 121.7 (C-5”); 
116.4 (C-3”); 112.9 (C-4); 51.9 (MeO); 24.9 (-CH2-). EI-MS: m/z = 386.2 [M]
+
. 
 
Experimental-Part 3B  
Preparation of endoperoxides 6 via Dye-sensitized photooxygenation of 
furans 1a-c, l-p: A solution of furan 1 (0.5 mmol) in anhydrous dichloromethane 
27.8 mL (0.018 M) was irradiated at -20 °C in the presence of methylene blue (MB, 1 
mg, 3×10
-3
 mmol) while dry oxygen was bubbled through the solution. The progress of 
the reaction was checked by periodically monitoring (
1
H-NMR) until the disappearance 
of starting furan (typically 2-3 h) and the intermediate endoperoxide 6 was identified by 
1
H-NMR. Compounds 6a-c were known and were identified by comparison of NMR data 
with those reported (DellaGreca et al. 2013). 
O O
O
COOMeMeOOC
6l  
DIMETHYL 1-CYCLOHEXYL-2,3,7-TRIOXA-BICYCLO[2.2.1]HEPT-5-ENE-5,6-DICARBOXYLATE (6l): 
1
H 
NMR (500MHz, CDCl3)  6.63 (s, 1H), 3.85 (s, 3H, OCH3), 3.90 (s, 3H, OCH3), 2.45 (m, 
1H), 2.03-1.17 (m, 10H). 
  
O O
O
MeOOC
6m
O
OMe
 
METHYL 6-(4-METHOXYBENZOYL)-4-PHENYL-2,3,7-TRIOXA-BICYCLO[2.2.1]HEPT-5-ENE-5-
CARBOXYLATE  (6m): 
1
H NMR (500MHz, CDCl3)  7.84 (d, J = 8.6 Hz, 2H, Ar-H), 7.64 (m, 2H, 
Ar-H), 7.45 (m, 3H, Ar-H), 6.98 (d, J = 8.6 Hz, 2H, Ar-H), 6.72 (s, 1H), 3.88 (s, 3H, OCH3), 
3.38 (s, 3H, OCH3). 
O O
O
COOMe
6n
O
MeO
 
METHYL6-(4-METHOXYBENZOYL)-1-PHENYL-2,3,7-TRIOXA-BICYCLO[2.2.1]HEPT-5-ENE-5-
CARBOXYLATE (6n): 
1
H NMR (500MHz, CDCl3)  7.65 (d, J=8.6 Hz, 2H, Ar-H), 7.42 (m+d, 7H, 
Ar-H), 6.80 (s, 1H), 3.88 (s, 3H, OCH3), 3.72 (s, 3H, OCH3). 
O O
O
CH2OAcMeOOC
6o  
METHYL 6-(ACETOXYMETHYL)-4-PHENYL-2,3,7-TRIOXA-BICYCLO[2.2.1]HEPT-5-ENE-5-CARBOXYLATE 
(6o): 
1
H NMR (500MHz, CDCl3)  7.57 (m, 2H, Ar-H), 7.48 (m, 3H, Ar-H), 6.65 (s, 1H), 
5.38 (d, J = 15.9 Hz, 1H),5.15 (d, J = 15.9 Hz, 1H),3.64 (s, 3H, OCH3), 2.19 (s, 3H, CH3). 
O O
O
MeOOC
6p
OMe
 
METHYL 6-(4-METHOXYBENZYL)-4-PHENYL-2,3,7-TRIOXA-BICYCLO[2.2.1]HEPT-5-ENE-5-
CARBOXYLATE  (6p): 
1
H NMR (500MHz, CDCl3)  7.55-7.33 (m, 7H, Ar-H), 6.83 (d, J = 8.0 
Hz, 2H, Ar-H), 6.21 (s, 1H), 4.21 (m, 2H, -CH2-),3.78 (s, 3H, OCH3), 3.63 (s, 3H, OCH3).  
 
  
In situ reduction of endoperoxides 6 with Et2S: To the photooxygenation 
solution containing the crude endoperoxide 9 at the oxygenation temperature, Et2S (65 
L, 0.6mmol, 1.2 eq) was added, and the mixture was kept at room temperature for 2-3 
h. The excess of Et2S and the solvent were removed in vacuo, and the crude aldehydes 
7a-c,m (yields>85%), 7n (yield>40%) and 7p (yield>20%) were characterized 
spectroscopically. No identifiable product was present in the reduction mixtures of 
furans 1l,o. 
Attempts to purify compounds 7a-c,m,n,p by preparative TLC drastically decreased 
yields. For example, 7a was obtained as an oil in <20% yield by silica gel TLC using 
hexane-EtOAc (8:2 v/v) as eluent. 
MeOOC COOMe
CHO
O
7a  
DIMETHYL 2-BENZOYL-3-FORMYLMALEATE (7a): 
1
H NMR (500MHz, CDCl3)  9.95 (s, 1H, CHO), 
8.04 (d, J = 8.0 Hz, 2H, Ar-H), 7.59 (m, 1H, Ar-H), 6.98 (br t, J=7.5 Hz, 2H, Ar-H), 3.89 (s, 
3H, OCH3), 3.72 (s, 3H, OCH3); 
13
C NMR (126MHz, CDCl3) 187.6 (CHO), 186.6 (CO), 165.1 
(C-4), 162.9 (C-1), 147.0 (C-2), 136.8 (C-3), 134.9 (C-1’), 129.3 (C-2’ and C-6’), 129.1(C-3’ 
and C-5’), 128.0 (C-4’), 53.9 (OCH3), 53.4 (OCH3); EI-MS: m/z=276.0 [M]
+
.  
MeOOC COOMe
CHO
O
7b
MeO
 
DIMETHYL 2-FORMYL-3-(4-METHOXYBENZOYL)MALEATE (7b): 
1
H NMR (500MHz, CDCl3)  9.64 
(s, 1H, CHO), 7.90 (d, J = 9.0 Hz, 2H, Ar-H), 6.97 (d, J= 9.0 Hz, 2H, Ar-H), 3.92 (s, 3H, 
OCH3), 3.88 (s, 3H, OCH3), 3.79 (s, 3H, OCH3);
 13
C NMR (126MHz, CDCl3)  δ 187.6 (CHO), 
186.6 (CO), 165.1 (C-4), 163.6 (C-1), 163.1 (C-4’), 147.0 (C-3), 137.2 (C-2), 131.9 (C-2’ 
and C-6’), 128.3 (C-1’), 114.5 (C-3’ and C-5’), 55.7 (OCH3), 53.6 (OCH3), 53.1 (OCH3); EI-
MS: m/z = 306.2 [M]
+
.   
  
MeOOC COOMe
CHO
O
7c
Br
 
DIMETHYL 2-(4-BROMOBENZOYL)-3-FORMYLMALEATE (7c): 
1
H NMR (500MHz, CDCl3)  9.68 (s, 
1H, CHO), 7.77 (d, J = 8.5 Hz, 2H, Ar-H), 7.65 (d, J = 8.5 Hz, 2H, Ar-H), 3.92 (s, 3H, OCH3), 
3.80 (s, 3H, OCH3); 
13
C NMR (126 MHz, CDCl3) δ 188.7 (CHO), 186.5 (CO), 163.2 (C-4), 
162.7 (C-1), 147.0 (C-2), 138.0 (C-3), 136.0 (C-4’), 132.5 (C-2’ and C-6’), 130.5 (C-3’ and 
C-5’), 128.0 (C-1’), 53.8(OCH3), 53.2(OCH3); EI-MS: m/z = 354.1 [M]
+
, 356.0 [M]
+
. 
 
MeOOC
CHO
O
7m
O
OMe
 
(Z)-METHYL 2-BENZOYL-3-FORMYL-4-(4-METHOXYPHENYL)-4-OXOBUT-2-ENOATE (7m): 
1
H NMR 
(500MHz, CDCl3)  9.71 (s, 1H, CHO), 8.00 (d, J = 8.9 Hz, 2H, Ar-H), 7.88 (d, J = 8.8 Hz, 
2H, Ar’-H), 7.68 (m, 1H, Ar-H), 7.55 (t, J = 7.7 Hz, 2H, Ar-H), 6.98 (d, J = 8.9 Hz, 2H, Ar’-
H),  3.86 (s, 3H, OCH3), 3.59 (s, 3H, OCH3); 
13
C NMR (126MHz, CDCl3) δ 190.4 (CHO), 
187.9 (CO and C-4), 165.1 (C-1), 163.0 (C-4”), 147.1 (C-2), 143.9 (C-3), 135.7 (C-1”), 
135.1 (C-1’), 132.4 (C-4’), 131.2 (C-2” and C-6”), 129.4 (C-2’ and C-6’), 129.3 (C-3’ and C-
5’), 114.3 (C-3” and C-5”), 55.6 (OCH3), 53.4 (OCH3); EI-MS: m/z = 352.2 [M]
+
. 
COOMe
CHO
O
7n
OMeO
 
(Z)-METHYL 3-BENZOYL-2-FORMYL-4-(4-METHOXYPHENYL)-4-OXOBUT-2-ENOATE (7n): 
1
H NMR 
(500MHz, CDCl3)  9.95 (s, 1H, CHO), 8.07-8.01 (m, 4H, Ar-H), 7.61 (t, J = 8.9 Hz, 1H, Ar-
H), 7.48 (t, J = 7.7 Hz, 2H, Ar-H), 6.97 (d, J = 8.3 Hz, 2H, Ar’-H),  3.86 (s, 3H, OCH3), 3.69 
(s, 3H, OCH3). 
  
MeOOC
CHO
O
7p
OMe
 
(E)-METHYL 2-BENZOYL-3-FORMYL-4-(4-METHOXYPHENYL)BUT-2-ENOATE (7p): 
1
H NMR 
(400MHz, CDCl3)  9.61 (s, 1H, CHO), 7.90 (d, J = 8.2 Hz, 2H, Ar-H), 7.64 (m, 1H, Ar-H), 
7.50 (t, J = 7.7 Hz, 2H, Ar-H), 7.27 (obscoured by solvent, 2H, Ar’-H), 6.84 (d, J= 8.7 Hz, 
2H, Ar’-H), 3.86 (s, 3H, -OCH3), 4.08 (s, 2H, -CH2-), 3.79 (s, 3H, -OCH3), 3.74 (s, 3H, -
OCH3). 
 
Conversion of Aldehydes 7a,c,m,n  to dioxabicyclohexenes 8a,c,m,n: 
When these aldehydes were kept in CDCl3 at r.t., they partly converted to compounds 
8. Attempts to isolate the latter by chromatography failed and were characterized in 
mixture with the corresponding aldehydes. 
O
OMeOOC
MeOOC
8a
H
 
DIMETHYL 1-PHENYL-5,6-DIOXA-BICYCLO[2.1.1]HEX-2-ENE-2,3-DICARBOXYLATE (8a) (7a/8a ca 1:1 
molar ratio) :
1
H NMR (400MHz, CDCl3): 7.68 (m, 2H, Ar-H), 6.14 (s, 1H, CH), 3.80 (s, 
3H, OCH3), 3.63 (s, 3H, OCH3). 
O
OMeOOC
MeOOC
8b
H
MeO  
DIMETHYL 1-(4-METHOXYPHENYL)-5,6-DIOXABICYCLO[2.1.1]HEX-2-ENE-2,3-DICARBOXYLATE (8b) 
(7b/8b ca 9:1 molar ratio):
1
H NMR (400MHz, CDCl3) 7.40 (d, J=9.0 Hz, 2H, Ar-H), 6.81 
(d, J=9.0 Hz, 2H, Ar-H), 6.13 (s, 1H, CH), 3.86 (s, 3H, OCH3), 3.80 (s, 3H, OCH3), 3.63 (s, 
3H, OCH3). 
  
O
OMeOOC
MeOOC
8c
H
Br  
DIMETHYL 1-(4-BROMOPHENYL)-5,6-DIOXA-BICYCLO[2.1.1]HEX-2-ENE-2,3-DICARBOXYLATE (8c) 
(7c/8c ca 1:3 molar ratio): 
1
H NMR (400MHz, CDCl3)  7.44 (d, J=8.2 Hz, 2H, Ar-H), 7.38 
(d, J=8.2 Hz, 2H, Ar-H), 6.13 (s, 1H, CH), 3.81, (s, 3H, OCH3), 3.64 (s, 3H, OCH3); 
13
C NMR 
(101MHz, CDCl3) δ 131.1, 128.0, 107.6, 99.6, 53.4, 52.4. 
O
OMeOOC
8m
H
OMe
O
 
METHYL 3-(4-METHOXYBENZOYL)-1-PHENYL-5,6-DIOXABICYCLO[2.1.1]HEX-2-ENE-2-CARBOXYLATE 
(8m) (7m/8m ca 9:1 molar ratio): 
1
H NMR (400MHz, CDCl3)   6.13 (s, 
1
H, CH), 3.83 (s, 
3H, OCH3), 3.32 (s, 3H, OCH3). 
O
O
MeOOC
8n
H
O
MeO  
METHYL 3-(4-METHOXYBENZOYL)-4-PHENYL-5,6-DIOXA-BICYCLO[2.1.1]HEX-2-ENE-2-
CARBOXYLATE(8n) (7n/8n ca 2:1 molar ratio): 
1
H NMR (400MHz, CDCl3)   6.33 (s, 1H, 
CH), 3.79 (s, 3H, OCH3), 3.58 (s, 3H, OCH3). 
DIMETHYL 5-(4-METHOXYPHENYL)-2-OXO-2,3-DIHYDROFURAN-3,4-DICARBOXYLATE (10b). When 
the reduction mixture of aldehyde 7b was kept in CdCl3 at rt and/or chromatographed 
by silica gel TLC,  lactone 10b was isolated in c.a. 30%. 
 
  
O
MeOOC
10b
O
COOMe
H
 
10b: oil; IR (CH2Cl2) 1813, 1747, 1731, 1604, 1512, cm
-1
; 
1
H NMR (500MHz, CDCl3) : 
8.06 (d, J = 9.0 Hz, 2H, Ar-H), 6.97 (d, J = 9.0 Hz, 2H, Ar-H), 4.75 (s, 1H, CH), 3.88 (s, 3H, 
OCH3), 3.84 (s, 3H, OCH3), 3.76 (s, 3H, OCH3); 
13
C NMR (126MHz, CDCl3)  167.6 (C-2), 
165.1 (COOCH3), 162.7 (COOCH3), 162.4 (C-4’), 161.9 (C-5), 131.8 (C-2’ and C-6’), 118.6 
(C-1’), 114.8 (C-3’ and C-5’), 113.6 (C-4), 55.5 (OCH3), 53.6 (OCH3), 53.1 (OCH3), 52.0 (C-
3); EI-MS: m/z = 306.0 [M]
+
.  
 
 
Oxidations of furan 1b by different routes: To a stirred solution of 1b (50 mg, 
0.17 mmol) in 1 mL of CH2Cl2 NaHCO3 (19 mg) was added. The mixture was cooled to 
0°C and then mCPBA (34 mg, 0.19 mmol) was added. The reaction was kept at r.t. 
overnight and then worked as reported by Gingerich et al. (Piancatelli et al. 1994; 
Kobayashi et al.1998; Gingerich et al. 1984) 
1
H-NMR analysis of the residue indicated 
the presence of only starting furan 1b. 
Furan 1b (50 mg, 0.17 mmol) was dissolved in 2 mL of THF-H2O (4:1) and cooled to 0°C. 
A stoichiometric amount of NBS was then added portionwise while the  temperature 
was being kept to r.t. overnight. The reaction was then worked as reported by 
Kobayashi et al. 
1
H-NMR analysis of the residue indicated the presence of furan 1b 
(32%), aldehyde 7b (20%) and unidentified material (48%).  
 
In situ base treatment of endoperoxides 6: Once the conversion of furan into 
endoperoxide 6 was complete the irradiation was stopped and Et2NH (62 L, 0.6 mmol, 
1.2 eq) was added, and the mixture was kept at r.t. for 30 min. The solvent and Et2NH 
were evaporated and the residue dried in the presence of anhydrous P2O5.  The crude 
acrylic acid 11(yield>90%, except for 11p purity 55%)was analyzed spectroscopically. 
Compounds 11a-c were identified according to literature data (DellaGreca et al. 2013). 
  
 
Attempts to purify  acids 11 by silica gel chromatography failed. 
 
MeOOC COOMe
COOH
O
11l  
(Z)-3-(CYCLOHEXANECARBONYL)-4-METHOXY-2-(METHOXYCARBONYL)-4-OXOBUT-2-ENOIC ACID 
(11l): amorphous powder; IR (CH2Cl2) 1739, 1641, 1255, 1166 cm
-1
; 
1
H NMR (500MHz, 
CDCl3) 9.01(br s, 1H, COOH), 3.83 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 2.59  (m, 1H), 
2.00-1.22 (m, 10H); 
13
C NMR (126MHz, CDCl3) 203.2 (CO), 166.2 (C-1 and C-4), 
163.7(COOCH3), 154.2 (C-2), 138.0 (C-3), 53.3 (OCH3), 52.9 (OCH3), 50.4 (C-1’), 28.2 (C-2’ 
and C-6’), 26.0 (C-3’ and C-5’), 25.6 (C-4’); EI-MS: m/z = 298.0 [M]
+
.  
MeOOC
COOH
O
11m
OMe
O
 
(E)-3-BENZOYL-4-METHOXY-2-(4-METHOXYBENZOYL)-4-OXOBUT-2-ENOIC  ACID (11m): 
amorphous powder; IR (CH2Cl2) 3054, 1700, 1640, 1570, 1250, 1030 cm
-1
; 
1
H NMR 
(500MHz, CDCl3) 7.94 (d, J=9.0 Hz, 2H, Ar-H), 7.88 (d, J=9.0 Hz, 2H, Ar-H), 7.49 (t, 
J=7.5 Hz, 1H, Ar-H), 7.39 (t, J=7.5 Hz, 2H, Ar-H), 6.90 (d, J = 7.5 Hz, 2H, Ar-H), 3.85 (s, 3H, 
OCH3), 3.50 (s, 3H, OCH3); 
13
C NMR (126MHz, CDCl3) δ 192.1 (2 x CO), 166.3 (C-1), 164.0 
(C-4), 163.5 (C-4”), 138.6 (C-2), 136.3 (C-3), 132.7 (C-1’), 131.2 (C-1”, C-2” and C-6”), 
129.0 (C-3’andC-5’), 128.5 (C-2’ and C-6’), 128.4 (C-4’), 114.2 (C-3” and C-5”), 55.5 
(OCH3), 52.7 (OCH3); EI-MS (m/z) = 368.0 [M]
+
.  
COOMe
COOH
O
11n
O
MeO
 
(E)-2-CARBOMETHOXY-3-(4-METHOXYBENZOYL)-4-PHENYL-4-OXOBUT-2-ENOIC ACID (11n): 
amorphous powder; IR (CH2Cl2) 1735, 1664, 1594, 1241, 1164 cm
-1
;
1
H NMR (500MHz, 
  
CDCl3)  8.05 (br d, J = 8.3 Hz, 2H, Ar-H), 8.02 (d, J = 8.9 Hz, 2H, Ar’-H), 7.50 (t, J = 7.3 Hz, 
1H, Ar-H), 7.41 (t, J = 7.6 Hz, 2H, Ar-H), 6.91 (d, J = 8.9 Hz, 2H, Ar’-H), 3.85 (s, 3H, OCH3), 
3.47 (s, 3H, OCH3); 
13
C NMR (126MHz, CDCl3) δ 192.8 (CO), 190.9 (C-4), 166.9 (C-1), 
165.8 (COOCH3), 164.1 (C-4”), 148.5 (C-3), 136.4 (C-2), 132.4 (C-2” and C-6”), 129.7 (C-2’ 
and C-6’), 129.6 (C-3’ and C-5’), 128.8 (C-4’), 128.5 (C-1’), 127.8 (C-1”), 114.4 (C-3” and 
C-5”), 55.6 (OCH3), 51.7 (OCH3); EI-MS (m/z) = 368.1 [M]
+
. 
 
MeOOC CH2OAc
COOH
O
11o  
(E)-2-(ACETOXYMETHYL)-3-BENZOYL-4-METHOXY-4-OXOBUT-2-ENOIC ACID  (11o) :amorphous 
powder; IR (CH2Cl2) 1727, 1676, 1362, 1074 cm
-1
; 
1
H NMR (400MHz, CDCl3) δ 7.90 (d, J = 
8.8 Hz, 2H , Ar-H), 7.50 (m, 1H, Ar-H), 7.42 (m, 2H, Ar-H), 5.30 (s, 2H, -CH2-), 3.66 (s, 3H, 
OCH3), 2.04 (s, 3H, CH3); 
13
C NMR (101MHz, CDCl3) δ 188.8 (CO), 170.6 (OCOCH3), 169.0 
(C-1), 164.2 (C-4), 145.0 (C-2), 136.4 (C-3), 132.4 (C-1’), 132.0 (C-4’), 128.4 (C-2’, C-3’, C-
5’ and C-6’), 60.6(-CH2O-), 52.5 (OCH3), 20.7 (CH3). EI-MS (m/z) = 306.0. 
MeOOC
COOH
O
11p
OMe
 
 (E)-3-BENZOYL-4-METHOXY-2-(4-METHOXYBENZYL)-4-OXOBUT-2-ENOIC  ACID (11p) (60% purity) 
: 
1
H NMR (400MHz, CDCl3)  7.85 (br d, J = 8.5 Hz, 2H, Ar-H), 7.50-7.04 (m, 5H, Ar-H and 
Ar’-H), 6.75 (d, J = 8.5 Hz, 2H, Ar’-H), 4.13 (s, 2H, -CH2-), 3.75 (s, 3H, OCH3), 3.63 (s, 3H, 
OCH3); 
13
C NMR (101MHz, CDCl3) δ 194.7 (CO), 171.0 (C-1), 165.9 (C-4), 158.0 (C-4”), 
137.2 (C-3), 137.0 (C-2), 132.3 (C-1’), 131.1 (C-1”), 130.3 (C-2” and C-6”), 128.6 (C-3’ and 
C-5’), 128.3 (C-2’, C-4’ and C-6’), 113.5 (C-3” and C-5”), 55.2 (OCH3), 52.1 (OCH3), 34.8 (-
CH2-). 
 
  
Mb-sensitized photooxygenation of furans 1 in acetone: A solution of furan 
(0.5 mmol) in anhydrous acetone (27.8 mL, 0.018 M) was irradiated at -20 °C (-60°C for 
1o,p) in the presence of methylene blue (MB, 1 mg, 3×10
-3
 mmol) while dry oxygen was 
bubbled through the solution. The progress of the reaction was checked by periodically 
monitoring (
1
H-NMR) until the disappearance of starting furan (typically 2-3 h). After 
completion of the reaction, the solution was warmed at r.t. and kept at this 
temperature for 12 h. The solvent was removed under reduced pressure. The crude -
hydroxybutenolides 12a-c,l,m (yields > 85%) were spectroscopically characterized. In 
the other series proton spectra showed complex mixtures.  
Compounds 12 could be purified and obtained in similar yields by silica gel filtration 
using CH2Cl2-EtOAc (95:5 v/v). 
O O
COOMeMeOOC
HO
12a  
DIMETHYL 5-HYDROXY-2-OXO-5-PHENYL-2,5-DIHYDROFURAN-3,4-DICARBOXYLATE (12a): 
IR(CH2Cl2) 3524, 1788, 1744, 1673 cm
-1
; 
1
H NMR (400MHz, CDCl3) δ 7.62 (d, J = 8.0 Hz, 
2H, Ar-H), 7.44 (m, 3H, Ar-H), 2.68 (br s, 1H, OH), 3.92 (s, 3H, OCH3), 3.77 (s, 3H, OCH3); 
13
C NMR (101MHz, CDCl3)  165.1 (C-2), 163.3 (COOCH3), 162.4 (COOCH3), 135.0 (C-4), 
131.8 (C-3), 131.3 (C-1’), 130.5 (C-4’), 128.7 (C-2’ and C-6’), 128.0 (C-5), 126.9 (C-3’ and 
C-5’), 52.9 (2 x OCH3). 
O O
COOMeMeOOC
HO
12b
MeO
 
DIMETHYL 5-HYDROXY-5-(4-METHOXYPHENYL)-2-OXO-2,5-DIHYDROFURAN-3,4-DICARBOXYLATE 
(12b): IR (CH2Cl2) 3463, 1802, 1731, 1692; cm
-1
; 
1
H NMR (500MHz, CDCl3) 7.75 (d, J = 
8.4 Hz, 2H, Ar-H), 6.97 (d, J = 8.4 Hz, 2H, Ar-H), 4.79 (br s, 1H, OH), 3.93 (s, 3H, OCH3), 
3.87 (s, 3H, OCH3), 3.77 (s, 3H, OCH3); 
13
C NMR (126MHz, CDCl3)  164.1 (C-2 and 
(COOCH3), 162.1 (COOCH3), 152.3 (C-4’), 130.6 (C-4), 130.3 (C-3, C-2’ and C-6’), 127.5 (C-
1’), 114.1 (C-5, C-3’ and C-5’), 55.4 (OCH3), 53.4 (OCH3), 53.2 (OCH3). 
  
O O
COOMeMeOOC
HO
12c
Br
 
DIMETHYL 5-(4-BROMOPHENYL)-5-HYDROXY-2-OXO-2,5-DIHYDROFURAN-3,4-DICARBOXYLATE (12c) 
: IR (CH2Cl2) 3557, 1799, 1741, 1676 cm
-1
; 
1
H NMR (400MHz, CDCl3) 7.55 (d, J= 8.6, 
2H, Ar-H), 7.51 (d, J= 8.6 Hz, 2H, Ar-H), 3.92 (s, 3H, OCH3), 3.77 (s, 3H, -OCH3), 2.41 (br s, 
1H, OH); 
13
C NMR (101MHz, CDCl3)  166.8(C-2), 165.5 (COOCH3), 163.6 (COOCH3), 
145.2 (C-4), 135.4 (C-3), 131.9 (C-3’ and C-5’), 131.7(C-4’), 130.3 (C-1’), 128.6 (C-2’ and 
C-6’), 128.4 (C-5), 53.1 (2 x OCH3). 
O O
COOMeMeOOC
HO
12l  
DIMETHYL 5-CYCLOHEXYL-5-HYDROXY-2-OXO-2,5-DIHYDROFURAN-3,4-DICARBOXYLATE (12l): IR 
(CH2Cl2) 3400, 1787, 1743, 1440, 1041 cm
-1
;
1
H NMR (400MHz, CDCl3) 4.91 (br s, 1H, 
OH), 3.88 (s, 3H, OCH3), 3.84 (s, 3H, -OCH3), 2.10  (m, 1H), 1.80-1.02 (m, 10H); 
13
C NMR 
(101MHz, CDCl3)  164.5 (C-2), 161.2 (COOCH3), 160.3 (COOCH3), 156.9 (C-4), 127.2 (C-
3), 96.3 (C-5), 53.6 (OCH3), 53.4 (OCH3), 43.7 (C-1’), 31.0 (C-2’ and C-6’), 25.9 (C-3’ and 
C-5’), 23.0 (C-4’). 
O O
MeOOC
HO
12m
OMe
O
 
METHYL 5-HYDROXY-3-(4-METHOXYBENZOYL)-2-OXO-5-PHENYL-2,5-DIHYDROFURAN-4-
CARBOXYLATE (12m): IR (CH2Cl2) 3531, 1779, 1734, 1667 cm
-1
; 
1
H NMR (400MHz, CDCl3)  
7.90 (d, J = 8.5 Hz, 2H, Ar-H), 7.74 (br d, J = 7.0 Hz, 2H, Ar-H), 7.49 (m, 3H, Ar-H),  6.96 
(d, J = 8.5 Hz, 2H, Ar-H), 3.87 (s, 3H, OCH3), 3.54 (s, 3H, OCH3); 
13
C NMR (101MHz, CDCl3) 
δ 187.9 (CO), 164.9 (C-2 and COOCH3), 160.7 (C-4”), 135.0 (C-4), 131.7 (C-2” and C-6”), 
128.7 (C-3, C-2’ and C-6’), 128.2 (C-1’), 127.0 (C-3’ and C-5’), 124.3 (C-4’), 121.1 (C-1”), 
114.4 (C-3” and C-5”), 113.9 (C-5), 55.5 (OCH3), 52.8 (OCH3).  
  
 
 
 
 
 
 
 
 
 
Chapter 4. 
CONCLUSION AND PERSPECTIVES 
  
The PhD work has highlighted that furans go on to be an interesting class of 
heterocycles. New synthetic methods for their preparation and elaboration have been 
described that provide a significant tool for glycosides and lignan-like compounds with 
important implications in pharmacological applications. In particular, a novel 
methodology based on a one-pot process starting from glycosyl furans has been 
developed for the synthesis of spiro compounds and, in particular, of new chiral [6,6]-, 
[5,6]- and [5,5]-spiroketals of sugars. The spiroketal moiety represents a privileged 
substructure since it can be found in many simple as well as complex natural products 
characterized by important and assorted biological properties, from antibiotic to 
anticancer. It is to be noted that despite numerous methodologies for spiro compounds 
few synthetic strategies for derivatives oxidized at the 2-position are reported. Novel 
pyridazine C-nucleosides have also been synthetized by a one-pot procedure. The 
pyridazine nucleus and its 3-oxo derivatives have been recognized as versatile 
pharmacophores and great attention in last years has been devoted to the synthesis of 
these compounds.   
Interesting results have been obtained  in the field of polysustituted furans. 
Indeed, starting from aryl trisubstituted derivatives a novel synthetic method for 
diarylfurans with a lignan backbone has been developed using a variant  of the Friedel-
Crafts reaction. Preliminary biological tests have evidenced antibiotic activities of some 
derivatives. The presence of furan system in these compounds highlights manifold 
elaborations of the heterocyclic ring  to a variety of product types.    
In this context, in the field of dye-sensitized photooxygenation, starting from some 
trisubstituted furans bearing ,’electron withdrawing groups, previously not 
investigated, useful C-4 synthons have been obtained in excellent yields in one-pot 
manner. All the reaction conditions, based on the combination of photooxygenation 
with reduction or basic treatment, are particularly mild respect to classical oxidation 
procedures, often not compatible with functional groups which are frequently present 
in synthetic intermediates. Hence these procedure represents useful alternatives to 
classical methods. Many of compounds prepared have various lignan-like structures 
that confirm the role of furans in the synthesis of interesting products. 
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